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Abstract 
Unlike many teleosts, the estuarine killifish, Fundulus heteroclitus (mummichog), 
does not demonstrate a shift from estrogens (such as 17β-estradiol; E2) to progestogens 
(such as maturation inducing steroid; MIS) during ovarian development. While these 
hormonal changes associated with ovarian development have been previously described 
in mummichog, the primary focus of the current study was to extend those studies by 
investigating whether these hormonal patterns are associated with changes in gene 
expression within the steroidogenic pathway. Blood (plasma), ovary (tissue and ovarian 
follicles), liver, and brain were collected from female mummichog at various stages of 
maturation, classified as cortical alveolus, vitellogenic, early mature, late mature, and 
ovulating. Testosterone (T), E2 and MIS, measured from plasma and in vitro ovarian 
follicle incubations, confirmed that T and E2 production correlate with vitellogenesis and 
final maturation in mummichog, whereas MIS correlates with only final maturation, 
further establishing the lack of an E2 drop prior to maturation. To determine patterns in 
mummichog steroidogenic and hormone signalling pathways, gene expression of ovarian 
StAR (steroidogenic acute regulatory protein), cytochrome P450 enzymes, estrogen 
receptors (ERs), and gonadotropin receptors, along with hepatic vitellogenin (VTG1) and 
ERs, and brain P450 aromatase (P450arom; CYP19b), were determined by qPCR across 
ovarian development. The expression of P450arom (CYP19a1; converts T to E2), ERα, 
StAR (initiates cholesterol transport), P450scc (P450 side chain cleavage; converts 
cholesterol into pregnenolone), and hepatic VTG1 are associated with patterns of E2 
levels in maturing mummichog as expression remained continuously high or increased 
into late maturation; however, these genes did not follow trends exhibited in other 
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teleosts. CYP17 expression (converts pregnenolone to 17α-hydroxypegnenolone and then 
dehydroepiandrosterone, or converts progesterone to 17α-hydroxyprogesterone and then 
androstenedione) was not associated with E2 patterns in mummichog, or other teleosts; 
expression decreased across maturation in mummichog. The secondary focus of this 
thesis was to determine the effects of an exogenous estrogen (EE2; 17α-ethinyl estradiol) 
on maturing follicles. Although many teleost species exposed to environmentally-relevant 
concentrations (e.g., <10 ng/L EE2) in vivo respond with a decrease in egg production and 
reproductive steroid levels, mummichog do not exhibit similar effects at much higher 
concentrations (e.g., >100 ng/L EE2). Ovarian follicles (cortical alveolus, vitellogenic, 
early mature, and late mature) were exposed in vitro to 50 – 250 nM of EE2 in vitro for 
24 hours. While other studies have suggested that ovarian LHr and P450arom expression 
are estrogen-responsive in fish, addition of EE2 in vitro had no effect; T and MIS 
production were also unaffected. Overall, these studies confirm high levels of follicular 
E2 across maturation, accompanied by increasing or continuously high expression of 
ovarian ERα, StAR, P450scc, and P450arom, hepatic VTG1 and brain P450arom in 
maturing fish. The tolerance exhibited by mummichog to exogenous estrogens could be 
partially attributable to continuously high levels of E2 present in the maturing ovary, as 
EE2 during follicular incubations has no effect on presumed E2-responsive genes. 
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1.0 Introduction 
This thesis is focused on characterization of aspects within the reproductive 
endocrine system during ovarian development in the estuarine killifish, Fundulus 
heteroclitus (mummichog). In previous studies, ovarian E2 (17β-estradiol) during 
maturation was observed to be regulated differently than in other teleosts. This difference 
is explored in the context of mummichog’s relative insensitivity to exogenous estrogen 
exposure in comparison to other fish species. Chapter one provides an overview of the 
fish reproductive endocrine system in general, and the mummichog system in particular. 
Chapter two describes the experimental work undertaken for the thesis in manuscript 
format. Chapter three is a summary including a description of the integrative nature of the 
work. 
1.1 Female Fish Reproductive Physiology 
In the classical definition, endocrine glands secrete chemical messengers 
(hormones) directly into the circulatory system, to be transported to a target organ; the 
hormones control responses such as growth, reproduction, and metabolism (Rushton, 
2009). Reproductive processes and strategies have evolved extensively among fish 
(Miller and Kendall, 2009), and are controlled and regulated by a balance and 
interconnectivity among the hormones of the hypothalamus, pituitary and gonads, 
referred to as the hypothalamus-pituitary-gonadal (HPG) axis (Ramezani-Fard et al., 
2013). Gonadal hormones control reproductive processes such as spawning, 
spermatogenesis (production of sperm), and oogenesis (production of eggs) (Miller and 
Kendall, 2009).  
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1.1.1 The Hypothalamus-Pituitary-Gonadal (HPG) Axis (Overview) 
The HPG axis controls reproduction in fish, through the development of 
reproductive tissues and coordination of complex processes that occur during the annual 
reproductive cycle (Figure 1.1) (Thomas, 2008). The brain facilitates the release of 
gonadotropin-releasing hormones (GnRHs) (Yu et al., 1997). The GnRHs are tropic 
peptide neurohormones produced in the neurons of the hypothalamus, which are released 
from their neural terminals to stimulate the release of gonadotropin hormones (GtH), 
from gonadotropes of the pituitary (Parhar et al., 2002; Zohar et al., 1995). Binding of 
GnRH to specific receptors on the plasma membrane of gonadotrope cells in the pituitary 
causes the activation of intracellular signaling pathways, which regulate the release of 
gonadotropins from storage (Thomas, 2008). The pituitary gland is able to facilitate 
reproduction in fish by using a dual GtH system: FSH (follicle stimulating hormone) and 
LH (luteinizing hormone), which are produced in two distinct gonadotropes of the 
pituitary (Ohkubo et al., 2013).  
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Figure 1.1. Stimulatory processes in the hypothalamus-pituitary-gonadal (HPG) axis. 
Descriptions of the processes can be found in sections 1.1.1 and 1.1.2. A primary role of 
FSH is to stimulate E2 production, and a primary role of LH is to stimulate MIS 
production. (Modified from Clelland and Peng, 2009.) 
1.1.2 Gonadotropin, Steroid and Vitellogenin Regulation  
FSH and LH are glycoprotein hormones consisting of both an alpha subunit and a 
beta subunit; the beta subunit is unique for each gonadotropin (Ohkubo et al., 2013). In 
female fish, FSH and LH are released into the bloodstream and then bind to their 
respective cell surface ovarian receptors (FSHr and LHr) (Ohkubo et al., 2013). FSHr and 
LHr activation stimulates gonadal functions, including the synthesis and release of certain 
steroid hormones involved in reproduction (Evans, 1999; Peter and Yu, 1997; Wang and 
Ge, 2004). It was first determined in coho salmon, Oncorhynchus kisutch, that FSH is 
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primarily involved in regulating gonadal steroidogenesis in the early ovarian 
developmental stages, especially during vitellogenesis (Swanson et al., 1991; Ohkubo et 
al., 2013). During vitellogenesis, vitellogenin (a female-specific lipoprotein) is 
synthesized in the liver under the stimulation of ovarian 17β-estradiol (E2), and is 
secreted into the blood and transported to the ovary where it is taken up into the oocytes 
to stimulate egg yolk protein production during development of the oocyte (Hoar et al., 
1983). FSH’s dominant role in vitellogenesis is to stimulate E2 production and release 
from ovarian follicles into the bloodstream (Nagahama and Yamashita, 2008). In teleosts, 
E2 plays a crucial role in sexual differentiation, gonadal development and steroidogenesis 
(the synthesis of steroids) during the reproductive cycle (Menuet et al., 2005). E2 also 
influences pituitary gonadotrope activity, which will in turn control the gonads through 
the synthesis of gonadotropins (Menuet et al., 2005).  
LH’s primary function, on the other hand, is to regulate the final stages of ovarian 
development and spawning (Breton et al., 1998; Tyler et al., 1997), partially due to its 
ability to stimulate 17α, 20β-dihydroxy-4-pregnen-3-one (17α, 20β-P), or maturation 
inducing steroid (MIS), production from the granulosa cell layer of the ovarian follicle 
(Figure 1.1; Clelland and Peng, 2009; Nagahama and Yamashita, 2008). In most teleosts, 
17α, 20β-P is the most effective steroid in the induction of GVBD (germinal vesicle 
breakdown) which occurs once a follicle is mature (Nagahama, 1983; Nagahama, 1994). 
MIS is responsible for inducing resumption of meiosis in teleost oocytes (Nagahama and 
Yamashita, 2008). The mechanism of MIS activity involved in oocyte maturation 
involves a complex interaction between oocyte MIS receptors and signal transduction 
pathways via inhibitory G-proteins (Nagahama and Yamashita, 2008). The MIS signal 
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induces the formation of maturation-promoting factor (MPF) and further induces GVBD 
and oocyte maturation (Nagahama and Yamashita, 2008). 
1.1.3 Estrogen Receptor Activity 
The principal mediator of E2 activity is the nuclear estrogen receptor (Marino et 
al., 2006). Analyzing estrogen receptor activity furthers our understanding of how E2 is 
regulated and how it is involved in other signaling pathways. The activation of steroids, 
such as estradiol, can occur by both nuclear and membrane receptors. With membrane 
receptors, the steroid binds to receptors on the cell surface, resulting in activation of ion 
channels or intercellular secondary messengers (Thomas, 2008). With nuclear receptors, 
steroids bind to the hormone response elements on a gene and alter their transcription 
rates (Thomas, 2008). The gene expression of nuclear receptors is regulated by steroid 
hormones, so expression rates will fluctuate in response to changes in steroidogenesis 
(Thomas, 2008). The genomic effects of E2 are mediated by specific nuclear receptors 
(ERs), which are able to modulate specific gene activity by acting as ligand-dependent 
transcription factors; when receptors are bound to the dependent ligand, the target genes 
will be activated (Menuet et al., 2002). In teleosts, two ER subtypes have been identified: 
ERα and ERβ; there are two distinct forms of ERβ: ERβ1 and ERβ2 (Menuet et al., 
2002).  
1.2 Steroidogenesis 
Hormones are derived from cholesterol in the process known as steroidogenesis 
(Figure 1.2), which involves a number of intermediates and enzymatic conversions prior 
to their release from the gonads (Arukwe, 2008; Leusch and MacLatchy, 2003; Young et 
al., 2005). The synthesis of the different classes of gonadal steroids depends on the 
7 
 
delivery of the substrate cholesterol, and its conversion by three enzymes belonging to 
the cytochrome P450 superfamily (Young et al., 2005). Steroidogenic acute regulatory 
protein (StAR) is a sterol transport protein which initiates cholesterol transport into the 
mitochondria (Rone et al., 2009). Cytochrome P450 side-chain cleavage (P450 scc) is 
located at the inner mitochondrial membrane and converts cholesterol to pregnenolone 
(Young et al., 2005). Pregnenolone is a basal steroid that can serve as a substrate for 
cytochrome P450 C17; P450 C17 can catalyze the hydroxylation of pregnenolone to yield 
17α-hydroxypregnenolone and then dehydroepiandrostone, or the hydroxylation of 
progesterone to yield 17α-hydroxyprogesterone (17α-HP) and then androstenedione 
(Young et al., 2005). Testosterone (T) is created from the conversion of androstenedione 
with the enzyme 17β-HSD (HSD: hydroxysteroid dehydrogenase), which is later 
converted into 11-ketotestosterone (11-KT) in males. The synthesis of estrogens depends 
on cytochrome P450 aromatase (P450arom), which uses T as a substrate for conversion 
into E2; changes to P450arom are responsible for the drop in estrogen levels that can 
occur in many teleosts prior to maturation (Young et al., 2005). During the maturation of 
oocytes, post-vitellogenic follicles have to synthesize a large amount of MIS (Arukwe, 
2008). MIS is produced from the conversion of 17α-hydroxyprogesterone to 17α, 20β-P, 
with the enzyme 20β-HSD, which is believed to be initiated with a surge in LH 
production (Barry et al., 1990; Young et al., 2005).  
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Figure 1.2. The steroidogenic pathway, responsible for the production of sex steroids 
such as MIS, T and E2 from cholesterol through multiple enzymatic reactions as 
explained in section 1.2. (Modified from Young et al., 2005). 
9 
 
1.3 The Ovarian Development Cycle 
Ovarian development in teleosts varies from species to species, in both the 
duration of the cycle as well as the mechanisms involved in regulating the cycle; the 
duration of the cycle in fish can vary from a few days to a few years (Khan and Thomas, 
1999). Oocyte maturation is the process whereby ovarian follicles develop (with an 
enormous growth of oocytes due to accumulation of yolk proteins in cytoplasm) and 
become mature (including germinal vesicle breakdown, chromosome condensation, 
assembly of the meiotic spindle and formation of the first polar body) prior to ovulation, 
which is required for successful fertilization (Nagahama and Yamashita, 2008). 
Oogenesis (oocyte maturation) can be described in six major steps: formation of PGCs 
(germline segregation), transformation of PGCs into oogonia (sex differentiation), 
transformation of oogonia into oocytes (onset of meiosis), growth of oocytes while under 
meiotic arrest, resumption of meiosis (maturation), and expulsion of the ovum from its 
follicle (ovulation) (Patino and Sullivan, 2002).  
The ovarian follicle, which surrounds each oocyte, consists of two major cell 
layers: an outer thecal cell layer and an inner granulosa cell layer (Figure 1.3; Clelland 
and Peng, 2009). As oocytes grow, follicle cells multiply and form a continuous follicular 
layer (granulosa cell layer); the follicular layer changes in order to support, nourish and 
regulate oocyte development in a continuous manner (Nagahama, 1994). In teleosts, 
growth and development of ovarian follicles are dependent on the actions of 
gonadotropin FSH and the steroid E2; whereas maturation of ovarian follicles is regulated 
by gonadotropin LH and the steroid MIS (Nagahama and Yamashita, 2008). In the two-
cell type model, the thecal cell layer will secrete androgen substrates, such as T and 17α-
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HP, while under the influence of gonadotropins. In the granulosa cells, 17α-HP and 
testosterone will be converted into MIS and E2 (Nagahama and Yamashita, 2008; 
Yamashita et al., 1995). In this model, prior to ovulation, E2 levels decrease and allow for 
significantly increased levels of MIS, which is required to complete maturation of the 
oocyte (Nagahama and Yamashita, 2008). Human chorionic gonadotropin (hCG) is used 
in experimental studies of ovarian development, as it is effective in inducing in vitro, and 
sometimes in vivo, oocyte maturation and ovulation in some teleosts; hCG mimics LH 
activity (Harvey and Hoar, 1979; Zuberi et al., 2011). 
The stages of oogenesis in commonly-studied teleosts, e.g., zebrafish (Danio 
rerio), are generally divided into growth/developmental stages and maturational stages 
(Figure 1.4). The developmental stages of oogenesis encompass the primary growth, 
cortical alveolus, and vitellogenic stage, and are predominatly regulated by increasing 
levels of E2 and FSH. During primary growth (prior to stage 1), oocytes begin to grow in 
size while the germinal vesicle (GV; oocyte nucleus) appears in the center of the oocyte, 
and a single layer of follicle cells surrounds the oocyte, eventually forming a vitelline 
envelope (Lyman-Gingerich and Pelegri, 2007). Stage 1 (cortical alveolus) is when the 
cortical alveoli (bound vesicles) appear in the ooplasm and the vitelline membrane 
contains three separate layers which surrounds the oocyte (Lyman-Gingerich and Pelegri, 
2007). Stage 2 (vitellogenesis) is when oocytes undergo vitellogenesis and acquire large 
amounts of vitellogenin, displacing cortical alveoli to the cortex of the oocyte (Clelland 
and Peng, 2009; Lyman-Gingerich and Pelegri, 2007). Stages 3-5 are maturational stages, 
which are commonly initiated with the drop in E2 levels and rise in MIS and LH levels. 
The maturational stages of oogenesis allow for drastic morphological changes in 
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accordance with the progression of meiosis, and allow for GVBD as well; the GV, which 
is usually located in the center of the oocyte, migrates to the animal pole with hormonal 
stimulation, where GVBD can occur (Suwa and Yamashita, 2007). Stage 3 (early 
maturation) is when oocytes are able to respond to LH, secreted from the pituitary, and 
MIS, synthesized and secreted from the follicle following MPF (maturation promoting 
factor) stimulation (Yamashita, 2000). Stage 4 (late maturation) is when the germinal 
vesicle migrates from the center of the oocyte to the periphery and the nuclear membrane 
breaks down (Selman et al., 1993). Stage 5 (ovulated) is when mature eggs are ovulated 
(oocyte is released from follicle complex and are ready for spawning; Lyman-Gingerich 
and Pelegri, 2007). 
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Figure 1.3. The two-cell type model in teleost oocytes. Major hormones, E2 (17β-
estradiol), MIS (maturation inducing steroid), T (testosterone) and17α-HP (17α-
hydroxyprogesterone), involved in oocyte growth and maturation outlined in the two 
layers (theca and granulosa) of the oocyte are shown. Descriptions of these processes can 
be found in section 1.3. (Modified from Clelland and Peng, 2009). 
 
Figure 1.4. Stages of ovarian development in commonly-studied teleosts with a two-cell 
type model, which are regulated by processes as explained in section 1.3 and Figure 1.3, 
separated by oocyte development and oocyte maturation stages. Primary growth stage = 
prior to stage 1; stage 1 = cortical alveolus stage; stage 2 = vitellogenic stage; stage 3 = 
early maturation stage; stage 4 = late maturation stage; stage 5 = ovulated stage. 
Germinal vesicle (GV) breakdown occurs when oocytes become fully mature in stage 4. 
Regulation of hormones E2 (17β-estradiol) and MIS (maturation inducing steroid) are 
depicted with relative increasing and decreasing arrows. (Modified from Selman et al., 
1993).  
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In mummichog, however, thecal cells (endocrine cells which play an essential 
role in producing androgen substrate required for ovarian estrogen biosynthesis 
(Magoffin, 2005)) are not evident in the thecal layer (Nagahama, 1994). In mummichog, 
granulosa cells are the major site of steroid synthesis, and respond to mummichog 
pituitary extract in vitro (Petrino et al., 1989). The production of E2 and 17,20β-P does 
not require the involvement of two cell types (Petrino et al., 1989). Petrino et al. (1989) 
also concluded that 17, 20β-P plays a major role as a maturation inducing steroid in 
mummichog, even though it is not the only active steroid produced by maturing follicles 
(as E2 production remains high).  
1.3.1 Shift in Steroidogenesis Prior to Oocyte Maturation 
In most teleost ovarian development processes studied to date, there is a shift that 
occurs between the developmental stages and maturational stages in the ovarian 
development cycle; a shift from estrogenic to progestational steroid production when 
follicles progress from vitellogenesis to a prematurational stage (Nagahama and 
Yamashita, 2008). As mentioned earlier, E2 (regulated by FSH) is produced in correlation 
with vitellogenesis; whereas MIS (regulated by LH) is produced in correlation with the 
onset of maturation of oocytes. It has been demonstrated in several teleost fish that the 
steroid 17α, 20β-P (MIS) is the most effective steroid in stimulating oocyte maturation 
(Nagahama, 1983; Nagahama, 1987). In goldfish, Carassius auratus, E2 production 
reduces greatly in the prematurational stage when compared to vitellogenic follicles 
(Kagawa et al., 1984). Maximal production levels of T were reported in the tertiary yolk 
stage follicles with hCG (LH analogue) stimulation (Kagawa et al., 1984In coho salmon, 
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the concentration of E2 was reduced while the production of T and MIS increased with 
advancing oocyte development (Van Der Kraak and Donaldson, 1986).  
In mummichog, however, there is no shift detected as the levels of E2 are 
consistently high in all stages of follicles (Lin et al., 1987). Ultimately, high levels of E2 
coexist with high progestagen levels in mummichog (Lin et al., 1987). Lin et al. (1987) 
also demonstrated that mummichog gonadotropins show a noticeable species specificity, 
as mummichog follicles exhibit both a seasonal and size dependent responsiveness to 
gonadotropins; the steroidogenic responses of mummichog ovarian follicles were found 
to be very dependent on the stage of follicular development.  
1.4 Endocrine Disrupting Compounds   
There are numerous natural and anthropogenic chemicals discharged into 
freshwater and estuarine systems that are capable of disrupting the endocrine systems of 
aquatic organisms (Sumpter, 2005).  Endocrine-disrupting chemicals (EDCs) have been 
defined by the World Health Organization’s International Programme on Chemical 
Safety (2002), as: “an exogenous substance which alters function(s) of the endocrine 
system and ultimately causes adverse health effects in an organism, its offspring or (sub) 
populations.” EDCs have the potential to disturb sensitive hormone pathways that 
regulate growth and reproductive functions in aquatic organisms (Arcand-Hoy and 
Benson, 1998).  
 Fish are primary targets for waterborne endocrine disruptors, many of which are 
xenostrogens (synthetic or natural estrogen-mimicking or –blocking compounds) 
(Menuet et al., 2005), making the impact of xenostrogens on aquatic ecosystems and fish 
a subject of great interest. Reports of reproductive problems in North American and 
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European freshwater and marine fish populations have sparked a wave of research, and 
raised awareness on the potential risks of EDCs to human and environmental health 
(Diamanti-Kandarakis et al., 2009; UNEP/WHO, 2013). The feminization of male fish 
due to exogenous estrogen exposure has been demonstrated in several studies such as in 
Kidd et al.’s (2007) whole-lake study with fathead minnow (Pimephales promelas), 
which showed feminization in males following exposure to 5-6 ng/L of 17α-ethinyl 
estradiol (EE2), and ultimately a near extinction of the species studied from the lake. 
Schwindt et al. (2014) suggested that fish populations exposed to environmentally-
relevant EE2 concentrations may not recover from exposure, and recommended improved 
wastewater processing technology to improve removal of bioactive chemicals such as 
environmental estrogens. Understanding the mechanisms of action for xenostrogens is an 
important step in evaluating the impact of these substances on fish reproductive 
physiology, and of assessing risk to fish populations in vulnerable ecosystems 
(UNEP/WHO, 2013).  
1.4.1 EE2: 17α-Ethinyl Estradiol 
The synthetic steroid EE2 (Figure 1.5A), is one of the most commonly-used active 
ingredients for oral contraception and related medicines (Lange et al., 2001). Estrogenic 
EDCs (including estrone, E2, estriol, and EE2) have been shown to enter the aquatic 
environment via effluent discharges from sewage treatment works (Sun et al., 2014). The 
hormones present in pharmaceuticals (including synthetic estrogens) are not completely 
broken down through municipal wastewater sewage treatment plants (Ternes et al., 
1999). The chemical structure of EE2 differs slightly from the chemical structure of the 
natural estrogen, E2 (Figure 1.5B), by an additional ethinyl group in EE2; this difference 
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leads to changes in biodegradability, making EE2 more resistant to degradation of 
microorganisms in wastewater treatment systems (Ternes et al., 1999). As a result, 
wastewater effluent from municipal treatment plants discharge EE2 into receiving waters 
in both treated and untreated waste waters, and can be found at 0 to 34 ng/L in different 
bodies of water (rivers, estuaries, bays, lagoons, surface water, etc) internationally, as 
well as in sediments within those bodies of water (Aris et al., 2014; Monteiro and Boxall, 
2010). Compounding their reproductive effects, EE2 levels are a concern in aquatic 
environments because of EE2’s high resistance to the process of degradation and its 
tendency to absorb organic matter, accumulate in sediment and concentrate in biota (Aris 
et al., 2014; De Wit et al., 2010). Effluents from municipal wastewater contain mixtures 
of various estrogens and their mimics, varying in toxicity (Desbrow et al., 1998). Within 
this group of substances, EE2 is one of the more potent synthetic estrogens present, and 
has been linked to serious effects on fish development and reproductive status (Desbrow 
et al., 1998).  
 
A 
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Figure 1.5: The chemical structure of the synthetic estrogen, 17α-ethinylestradiol (EE2; 
A), and the natural estrogen, 17β-estradiol (E2; B) (Sigma-Aldrich, 2015). 
1.4.2 Effects of EE2 on Teleosts 
 It has been demonstrated that EE2 can negatively impact the reproductive system 
and related processes in several teleosts. These effects on the reproductive status and 
development of fish can have detrimental long-term effects on fish populations, which 
can also impact the ecosystem. Mummichog, however, typically respond at higher 
concentrations of EE2 (generally 100 ng/L or higher) compared to the levels (<10 ng/L) 
to which other fish respond. For instance, this can be seen when comparing population 
and reproductive health effects between commonly-studied freshwater teleosts and 
mummichog. EE2 exposure caused intersex (feminization) and induced vitellogenin 
(female egg yolk precursor protein) production in fathead minnow at 5-6 ng/L of EE2 
during a 7-year whole-lake experiment (Kidd et al., 2007), and in zebrafish when 
exposed to 5 ng/L EE2 in a full lifecycle exposure (Nash et al., 2004). Parrott and Blunt 
(2005) demonstrated significant effects on fathead minnow fertilization success, sex ratio, 
male secondary sex characteristics, GSI (gonadal somatic index), LSI (liver somatic 
index) and growth at 0.32-23 ng/L EE2 (nominal), or 0.0-1.5 ng/L of EE2 after RIA 
B 
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(radioimmunoassay) detection, 150 days post hatch. In mummichog, reproductive 
endpoints do not appear to be affected at similar concentrations of EE2, when compared 
to other teleosts. In mummichog, induced male plasma vitellogenin and vitellogenin 
mRNA has been demonstrated at higher concentrations of 100 ng/L EE2, after 21-day and 
14-day (respectively) exposures (Hogan et al., 2010; Peters et al., 2007). However, EE2-
treated mummichog larvae showed complete feminization (all treated larvae exhibited 
female phenotype) at 10 weeks post hatch, including a low exposure concentration of 10 
ng/L (Chehade, 2012), similar to effects in other species. 
Reproduction is impacted by EE2 exposure in teleosts, as egg production was 
significantly reduced in fathead minnow at concentrations of 0.47-3.92 ng/L after a 21-
day exposure (Armstrong et al., 2016). Other freshwater species such as Chinese rare 
minnow (Gobiocypris rarus) exposed to 0.2 ng/L EE2 (Zha et al., 2008) and zebrafish 
exposed to 1 ng/L EE2 (Lin and Janz, 2006) or 25 ng/L for seven days (Schilling, 2015) 
exhibited significantly reduced egg production. EE2 does not have such a consistent low-
concentration effect on reproduction in mummichog, as egg production decreased in 
females and fertilization decreased in males at only 100 ng/L, as assessed at 28 days 
(Peters et al., 2007). A study by Bosker et al. (2016), has further shown that the 
cumulative egg production per female was unaffected by high concentrations of EE2 at 
100 ng/L (nominal), or 84.1 ng/l ± 6.0 actual, after 28 days of exposure. 
EE2’s strong impacts on fish reproduction may be mediated by effect on sex 
steroids that regulate reproductive processes. In fish, estrogen mimics compete with 
naturally-occurring estrogen for binding to the estrogen receptors and disrupt the 
steroidogenic pathway, which can consequently depress plasma hormone levels (Hogan 
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et al., 2010). Hormones T, 11-KT and E2 were notably lower in male fathead minnow 
after exposure to 10 ng/L EE2 for 21 days (Salierno and Kane, 2009). In mummichog, 
some hormones were affected by EE2 at high (e.g., 100 ng/L) concentrations. Female 
plasma T and E2 significantly decreased after exposure to EE2 at 100 ng/L for 21 days; 
plasma E2 also decreased at 10 ng/L EE2 after 28 days (Peters et al., 2007). Hogan et al. 
(2010) demonstrated different effects, as male and female plasma T levels did not differ 
significantly among treatments of 100 and 500 ng/L (nominal) of EE2 for 14 days, or 67.9 
± 7.4 and 247.9 ± 12 (average) ng/L. Gillio Meina et al. (2013) demonstrated decreases 
in female E2 and male 11-KT at 250 ng/L EE2. These data substantiate the general trend 
of EE2 effects on mummichog at higher than environmental levels, unlike what has been 
found in most other fish species studied. 
EDCs have been shown to exert direct effects on gonadal steroidogenesis in 
teleosts through various mechanisms (Thomas, 2008). EDCs, such as exogenous 
estrogens, may disrupt the steroidogenic pathway by interfering with the gene expression 
of specific enzymes at key steps (Hogan et al., 2010). For instance, steroidogenic 
enzymes (P450scc, P450c17, and 3β-HSD) expression decreased with EE2 exposure (8 
days of oral treatment at 20 mg/kg) in rainbow trout (Baron et al., 2005). In fathead 
minnow, steroidogenic enzymes StAR, P450scc and P450c17 were downregulated with 
2-50 ng/L EE2; P450arom was not significantly altered, but showed a downward 
tendency (Garcia-Reyero et al., 2009). On the other hand, there was no effect on 
steroidogenic enzymes StAR, P450scc and P450arom in mummichog ovaries after a 14-
day exposure to 250 ng/L EE2 (Doyle et al., 2013).  
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1.4.3 Potential Mechanisms for High Sensitivity to EE2 in Mummichog 
The mechanistic reasons in mummichog for the differences in effects following 
EE2 exposure compared to other freshwater teleosts is not known. Previous studies have 
tried to determine the factors which cause lower sensitivity in mummichog by focusing 
on environmental and physiological variables. Environmental variables that have been 
investigated to some extent include salinity, temperature and hypoxia. Salinity was 
analyzed as mummichog live in estuarine environments with fluctuating salinity, and 
most fish commonly used in EE2 exposure studies are freshwater fish. Salinity increases 
EE2 uptake (Blewett et al., 2013), but has no significant effect on plasma steroids or 
gonadal steroidogenesis (Gillio Meina et al., 2013). Increased temperature results in 
greater EE2 uptake (Blewett et al., 2013). Increased temperature at 26
oC, compared to 
10oC and 18oC, resulted in increased gonad weight in male and female mummichog and 
decreased LSI, yet there was no interaction between temperature and EE2 on either 
plasma E2 or T in females, or plasma T and 11-KT in males (Gillio Meina et al., 2013). In 
hypoxia, there is little change on the effect on EE2 uptake in mummichog (Blewett et al., 
2013).  
Tissue distribution of EE2 accumulation after exposure in mummichog has also 
been examined through a comparative study to other species. In mummichog, gallbladder 
and liver accumulated the largest amount of radiolabeled EE2 (50%); the carcass and the 
gut were the next highest accumulators (Blewett et al., 2014). Alternatively, EE2 was 
quickly associated with the carcass (50%) in fathead minnow, goldfish, zebrafish and 
rainbow trout (Blewett et al., 2014). This could indicate that EE2 is potentially being 
metabolized and cleared more quickly in mummichog compared to other teleosts, thus 
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protecting the reproductive system from deleterious effects of EE2. This hypothesis has 
not been further investigated and, to date, is the most evidence-based explanation for the 
differences in EE2 sensitivity between mummichog and other fish species. 
1.5 Objectives  
The hypothesis for this thesis is that the differences in E2 regulation during 
ovarian development between mummichog and other teleosts may play a part in the 
species-specific sensitivity of mummichog to EE2. In most teleosts, the shift between the 
developmental stages and maturational stages in oogenesis is accompanied by a shift 
from estrogenic (E2) to progestational (MIS) steroid production when follicles progress 
from vitellogenesis to a prematurational stage (Nagahama and Yamashita, 2008). These 
key steroids, such as E2, T and MIS regulate the ovarian development cycle. E2 is 
stimulated by FSH and is produced in correlation with vitellogenesis (involved in 
developmental stages); whereas MIS is stimulated by LH and is produced in correlation 
with the onset of maturation of oocytes (involved in maturational stages). In mummichog, 
however, there is no shift detected as the levels of E2 are consistently high in all stages of 
follicles and coexist with high progestagen levels in mummichog (Lin et al., 1987). 
Because mummichog have continuously high levels of E2 across maturation, this may 
cause a decrease in ovarian sensitivity to EE2, possibly through molecular pathways in 
the steroidogenic pathway. EDCs, such as EE2, have been shown to exert direct effects on 
gonadal steroidogenesis in teleosts through various mechanisms, and also potentially 
alters gonadal steroid production at specific sites within the steroidogenic pathway 
(MacLatchy et al., 2003; Hogan et al., 2010; Peters et al., 2007; Thomas, 2008). 
Therefore, the present study focused on the molecular characterization of the ovarian 
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steroidogenic pathway across the maturational stages in mummichog to firstly, better 
understand the molecular changes that occur during steroidogenesis and secondly, the 
effects of EE2 in vitro on maturing ovarian follicles.  
The approach used was to initially replicate and confirm the current 
understanding of mummichog maturation as it relates to ovarian steroidogenesis (e.g., 
changes in plasma and follicular steroids during maturation), and to then add to the body 
of knowledge by characterizing for the first time the gene expression changes across the 
ovarian development cycle, using in vitro ovarian follicle incubations. With this deeper 
mechanistic understanding of mummichog ovarian steroidogenesis, it was then possible 
to undertake a preliminary in vitro ovarian follicle exposure across maturational stages to 
EE2, to determine the effect on gene expression endpoints known to be estrogen sensitive 
in other teleost species. Together, these studies have progressed our understanding of 
mummichog ovarian development and provided a potential addition to the mechanistic 
understanding of the general resistance of mummichog to environmentally-relevant levels 
of EE2. 
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2.1 Abstract 
This study investigated ovarian development in Fundulus heteroclitus 
(mummichog), through molecular characterization of key mediators in the ovarian 
steroidogenic pathway; these included ovarian StAR (steroidogenic acute regulatory 
protein), cytochrome P450 enzymes, estrogen receptors (ERα, ERβ1 and ERβ2), and 
gonadotropin receptors (FSHr and LHr); additionally, hepatic vitellogenin (VTG1) and 
ERs, and brain P450 aromatase (P450arom; CYP19b) were studied. Fish were staged into 
cortical alveolus, vitellogenic, early mature, late mature, and ovulating stages of 
maturation; blood (plasma), ovary (tissue and isolated ovarian follicles per stage), liver, 
and brains were collected. Testosterone (T), 17β-estradiol (E2) and maturation inducing 
steroid (MIS), measured from plasma and in vitro ovarian follicle incubations, confirmed 
that T and E2 production correlate with vitellogenesis and final maturation in 
mummichog, whereas MIS correlates with only final maturation in mummichog; no E2, 
as is present in other teleosts, drop prior to maturation was observed. The expression of 
P450arom (CYP19a1), ERα, StAR, P450 side-chain cleavage, and hepatic VTG1, 
determined by qPCR methods, were associated with patterns of E2 in maturing 
mummichog, but did not follow patterns exhibited in other teleosts. CYP17 expression 
was not associated with E2 patterns in mummichog, or other teleosts. To determine EE2 
(17α-ethinyl estradiol) effects during maturation, follicles grouped per stage were 
exposed to 50 - 250 nM of EE2 in vitro for 24 hours; there was no effect on P450arom or 
LHr expression, or on T or MIS production. The tolerance exhibited by mummichog to 
exogenous estrogens in vitro could be partially attributable to continuously high levels of 
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E2 present in the maturing ovary, as EE2 during follicular incubations had no effect on 
presumed E2-responsive genes. 
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2.2 Introduction 
In most teleost ovarian development processes studied to date, there is a shift that 
occurs from estrogenic (17β-estradiol or E2) to progestational (maturation inducing 
steroid or MIS; 17α, 20β-dihydroxy-4-pregnen-3-one) steroid production when follicles 
progress from vitellogenesis to a prematurational stage (Nagahama and Yamashita, 
2008). E2 is produced in correlation with early developmental stages and rises during 
vitellogenesis (the process of vitellogenin synthesis in the liver, under the stimulation of 
E2, and uptake into the oocytes; Hoar et al., 1983), whereas MIS is produced in 
correlation with the onset of maturation of oocytes (Nagahama and Yamashita, 2008). 
MIS role in maturation is to induce resumption of meiosis and germinal vesicle 
breakdown (GVBD) in teleost oocytes (Clelland and Peng, 2009; Nagahama and 
Yamashita, 2008). In mummichog there is no progestagen shift; the levels of E2 are 
consistently higher in all stages of follicles tested and coexist with increasing progestagen 
during mummichog (Lin et al., 1987). Similar to other teleosts, MIS continues has a 
major role in maturation of mummichog (Petrino et al., 1989).  
Ovarian development in teleosts varies from species to species, in both the 
duration of the cycle as well as the mechanisms involved in regulating the cycle (Khan 
and Thomas, 1999). Selman and Wallace (1986) characterized five stages of oogenesis; 
the first stage is the primary growth stage (definitive follicle is formed), the second stage 
is the cortical alveolus stage (contains randomly dispersed cortical alveoli, or “yolk 
vesicles”), the third stage is vitellogenesis (immense growth of the follicle occurs due to 
uptake of vitellogenin), the fourth stage is oocyte maturation, further separated into early 
maturation (follicular size increases due to hydration and protein uptake) and late 
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maturation (germinal vesicle breakdown occurs), and the fifth stage is ovulation (mature 
egg which is ready for ovulation). These stages resemble those as described for other fish 
species, including zebrafish (Clelland and Peng, 2009; Lyman-Gingerich and Pelegri, 
2007) and rainbow trout (Van Der Hurk and Peute, 1979). 
Ovarian development in teleost fish is controlled and regulated by a balance and 
interconnectivity among steroids and gonadotropins, through signalling pathways 
(Ramezani-Fard et al., 2013). In teleosts like mummichog, gonadotropins FSH (follicle 
stimulating hormone) and LH (luteinizing hormone) are released into the bloodstream 
from the pituitary and bind to their respective receptors (FSHr and LHr) on the ovary 
(Ohkubo et al., 2013; Shimizu et al., 2003). FSH is primarily involved in regulating 
gonadal steroidogenesis in the early developmental stages (primary growth – completion 
of vitellogenesis), as it correlates with E2 production, whereas LH is primarily involved 
in regulating oocyte maturation (early maturation – ovulation), as it correlates with MIS 
production (Ohkubo et al., 2013; Swanson et al., 1991). E2 action is mediated by estrogen 
receptors (ERs) which have the subtypes ERα (ESR1) and ERβ (including both ERβ1, or 
ESR2a, and ERβ2, or ESR2b; Menuet et al., 2002). It is presumed that the gene 
expression of ERs is regulated by steroid hormones, so expression rates will fluctuate in 
response to changes in steroidogenesis (Thomas, 2008); however, ESR1 is the only 
subtype that has been linked to biological function in previous studies, such as 
stimulation of vitellogenin synthesis in liver and E2 regulation (Chakraborty et al., 2011).  
All sex steroids are derived from cholesterol via a number of enzymatic 
conversions in a process known as steroidogenesis (Arukwe, 2008; Leusch and 
MacLatchy, 2003). Little is known about the expression of the genes involved in 
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regulation of the steroidogenic pathway across ovarian development in mummichog. 
These steroidogenic enzymes include: steroidogenic acute regulatory protein (StAR), 
which is a sterol transport protein that initiates cholesterol transport into the mitochondria 
(Rone et al., 2009); cytochrome P450 side-chain cleavage (P450scc, or CYP11), which 
produces pregnenolone (basal steroid) from cholesterol (Young et al., 2005); cytochrome 
P450 C17 (P450C17, or CYP17), which can catalyze the hydroxylation of pregnenolone 
to yield 17α-hydroxypregnenolone and then dehydroepiandrostone, or the hydroxylation 
of progesterone to yield 17α-hydroxyprogesterone and then androstenedione by 3β-HSD 
(Young et al., 2005); and cytochrome P450 aromatase (P450arom; CYP19a1 for ovarian, 
or CYP19b for brain), which converts T into E2 and is potentially responsible for the drop 
in estrogen levels that occur prior to maturation (Young et al., 2005).  
EDCs (endocrine disrupting compounds) have been shown to exert direct effects 
on gonadal steroidogenesis in teleosts through various mechanisms; EE2 (17α-ethinyl 
estradiol; a synthetic estrogen commonly found in municipal waste waters via birth 
control and hormone replacement therapy pharmaceuticals) can alter gonadal steroid 
production at specific sites within the steroidogenic pathway (Hogan et al., 2010; 
Thomas, 2008). EE2 is commonly used as a model compound to study the impact of 
estrogenic compounds on aquatic organisms, due to its environmental relevance and 
inability to be broken down in municipal wastewater treatment (Bosker et al., 2016). 
Mummichog exhibit a greater tolerance to EE2 when compared to other small-bodied 
species. For instance, a seven-year whole lake EE2 exposure demonstrated induced 
vitellogenin and the feminization of male fathead minnow (Pimephales promelas) at 5-6 
ng/L of EE2, and an eventual population collapse. Egg production was significantly 
36 
 
reduced in fathead minnow at concentrations of 0.47-3.92 ng/L of EE2 after a 21-day 
exposure (Armstrong et al., 2016), in Chinese rare minnow (Gobiocypris rarus) and 
zebrafish (Danio rerio) at concentrations as low as 0.2 ng/L EE2 and 1 ng/L EE2, 
respectively (Lin and Janz, 2006; Zha et al., 2008). Alternatively, mummichog respond to 
higher levels of EE2 at concentrations of 100 ng/L (Doyle et al., 2013; Gillio Meina et al., 
2013; Hogan et al., 2010; Peters et al., 2007). Confirming previous studies, Bosker et al. 
(2016) demonstrated that cumulative egg production per female was unaffected by high 
concentrations of EE2 at 100 ng/L (nominal), or 84.1 ng/l ± 6.0% of nominal, after 28 
days of exposure.  
Previous studies have tried to determine factors which cause lower sensitivity to 
EE2 in mummichog, by investigating environmental and physiological variables.  It was 
determined that there was no interaction between temperature and EE2, or salinity and 
EE2 on plasma steroid levels in mummichog (Gillio Meina et al., 2013). A tissue 
distribution study, however, showed that EE2 may be metabolized and cleared more 
quickly in mummichog, as mummichog accumulate EE2 to a greater degress in the 
gallbladder and liver, compared to the caracass in zebrafish and fathead minnow (Blewett 
et al., 2014). Because ovarian physiology differs in mummichog, primarily the lack of an 
E2 drop during maturation, it may be at least partially attributable to the decreased 
sensitivity of mummichog to EE2.  
The objectives of this study were to confirm the current understanding of 
mummichog maturation as it relates to ovarian steroidogenesis and to characterize the 
gene expression changes across the ovarian development cycle for the first time. With 
this deeper mechanistic understanding of mummichog ovarian steroidogenesis, it was 
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then possible to undertake a preliminary in vitro ovarian follicle exposure across 
maturational stages to EE2, to determine the effect on gene expression endpoints known 
to be estrogen sensitive in other teleost species. Together, these studies have progressed 
our understanding of mummichog ovarian development and provided a potential addition 
to the mechanistic understanding of the general resistance of mummichog to 
environmentally-relevant levels of EE2. 
 
 
  
38 
 
2.3 Materials and Methods  
2.3.1 Fish collection and holding 
Adult mummichog (6.07 – 21.1 g) were collected in June 2015 from Shemogue 
Harbour, NB, Canada (46° 10′ 35″ N, 64° 8′ 55″ W) by seine net (size of mesh: ¼”). The 
fish were transported to Wilfrid Laurier University in aerated plastic totes, and 
quarantined in 200 L plastic reservoirs for 14 days at room temperature with frequent 
water changes before being transferred and maintained in recirculating fish holding units. 
Fish were housed in 380 L single stock tanks (Aquabiotech Inc, Coaticook, QC, Canada) 
or held in a G-HAB unit consisting of 40 L and 60 L glass aquaria (Pentair, Apopka, FL, 
USA). Routine water quality tests (ammonia, nitrite and nitrate levels) and water changes 
(25% water change every two weeks and 50% water changes every month) were 
conducted to maintain conditions within desired levels. For all holding conditions, the 
water was maintained at 16-18 ppt salinity by the addition of artificial sea salt [Crystal 
Sea Marine Mix sea salt (Marine Enterprises International, Baltimore, MD, USA)] to 
City of Waterloo dechlorinated and reverse osmosis water. 
2.3.2 Characterization of the estrogen biosynthetic pathway during ovarian 
development  
In order to obtain ovaries at different stages during the reproductive cycle, 
photoperiod and temperature were adjusted in the stock tanks to mimic seasonal changes. 
The temperature and photoperiod began at 4oC and 8 h light: 16 h dark (held at these 
conditions for two weeks) to simulate a colder season and obtain regressed stages of 
ovarian follicles. The females were also separated from the males during this period and 
were fed commercial trout pellets (2mm; EWOS Pacific, Vancouver, BC, Canada) once a 
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day. Once sampling was complete (December 2015), the temperature and photoperiod 
was slowly raised to 12oC and 12 h light: 12 h dark (temperature was increased 1oC each 
day) to simulate warmer seasons and stimulate ovarian recrudescence and maturation. 
Males were added to the stock tanks and fish were fed commercial trout pellets twice a 
day; the temperature was also further increased slowly to 16oC. Once sampling was 
complete for the vitellogenic stage (April 2016), the temperature and photoperiod was 
slowly raised to 22oC and 16 h light: 8 h dark (spawning conditions) and fish were fed 
commercial trout pellets twice a day, and supplemented with freeze-dried blood worms 
(Glycera dibranchiata; BrineShrimpDirect, Ogden, UT, USA) once every other day. 
Maturing stages were easily collected at these conditions (April-May 2016). 
i) Sampling 
When female mummichog reached desired stages of ovarian development (as 
estimated from the increased size and softness of the female abdomen as it becomes 
larger with increasing ovarian development), fish were anaesthetized with ~0.05% ethyl 
3-aminobenzoate methanesulfonate salt (Sigma-Aldrich, Oakville, ON, Canada), bled 
from the caudal vasculature using heparinized 25 G 5/8 needles on 1 mL syringes, and 
killed by spinal severance after being weighed, as simplified in Figure S2.4. Fish were 
sampled on these dates: December 1st, 2015; April 12th, 15th and 20th, 2016; May 3rd, 
2016. The stage of ovarian development was classified with gross morphological 
assessment of the ovary following criteria listed in Table 2.1; the dominantly present 
stage (dominant stage ~ >75% of follicles in ovary) in samples were verified with 
histological assessment. Collected blood was kept on ice then centrifuged at 8000 x g for 
10 minutes at 4oC to isolate plasma. Plasma was pipetted and stored at -20oC in 1.5 mL 
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centrifuge tubes (Fisher Scientific, Ottawa, ON). E2, T and MIS levels were measured 
from plasma samples obtained from 15, 12, 16, 14, and 4 fish respectively classified as 
having ovaries with stage 1-5 follicles dominantly present. 
The ovary, liver, and brain (pituitaries were not isolated because of difficulty due 
to size) were dissected and removed, and ovary and liver were weighed. The ovary and 
liver weights, along with the whole-body weight, were used to calculate the GSI (gonadal 
somatic index) and LSI (liver somatic index) of each fish. 
GSI = 
𝑜𝑣𝑎𝑟𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
 x 100                                             LSI = 
𝑙𝑖𝑣𝑒𝑟 𝑤𝑒𝑖𝑔ℎ𝑡
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
 x 100 
The liver and brain were snap-frozen on dry ice, then stored at -80oC, to be used 
later for RNA extractions and molecular analysis. The ovary was divided into two 
sections: one section was snap-frozen on dry ice and stored at -80oC (utilized later for 
RNA extractions and molecular analysis) and another section was placed in 75% 
Leibovitz-15 (L-15) medium [L-15 powder with L-glutamine (Sigma-Aldrich) diluted 
with ultrapure water as per manufacturer’s instructions; medium was balanced to a pH of 
7.5 and contained 10 mL of penicillin streptomycin (Thermo Fisher Scientific, 
Burlington, ON, Canada)]. Gene expression was measured from ovary (tissue), liver 
(tissue) and brain (whole) samples obtained from 9-12, 10-11, 14-15, 14, and 4 fish 
classified as having ovaries with stage 1-5, respectively, follicles dominantly present. 
ii) In vitro methodology 
Whole ovary tissue was placed into glass petri dishes containing 75% L-15 
medium and gently teased apart using forceps to separate different stages of follicles. In 
order to classify follicles into stages, an EVOS XL digital inverted microscope imaging 
system (Life Technologies, Thermo Fisher Scientific) was used to identify morphological 
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characteristics and measure follicle diameter, which corresponded to criteria in Table 2.1. 
Example images of staged follicles are shown in Figure 2.1. The incubation protocol was 
modified from McMaster et al. (1995) and MacLatchy et al. (2003). Follicles grouped by 
stage were incubated in 1 mL (stages 1-3) or 2 mL (stages 4-5) of culture medium (75% 
L-15) for 24 hours at 18oC, as simplified in Figure S2.6A. Each well contained 24 mg of 
tissue (3 pieces of 7-8 mg) for stage 1 (cortical alveoli) ovaries or 15 follicles for stage 2-
5 follicles, from individual fish. Samples from each fish were distributed into 2-6 wells, 
depending on the available tissue or follicles. The wells were divided into two treatments: 
control [basal (medium only)] or hCG (human chorionic gonadotropin; Lee Biosolutions, 
Maryland Heights, MO, USA) treated at 20 IU/mL. Preliminary results showed that this 
concentration of hCG stimulated steroid production by follicles (data not shown) and has 
been used in other studies (MacLatchy et al., 2003). hCG is an analogue to LH 
(luteinizing hormone), an endogenous gonadotropin responsible for oocyte maturation 
and stimulation of steroidogenesis. After incubation, medium was removed and stored at 
-20oC, while tissue was removed and stored at -80oC. The medium was later used for 
steroid hormone measurement of E2, T and MIS through enzyme immunoassay (EIA) 
analysis; medium was obtained from 10, 15, 12, 16, and 10 fish for stages 1-5, 
respectively. 
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Table 2.1. Size and morphology classification of ovarian stages (Modified from Selman 
and Wallace, 1986), verified through examination under an EVOS XL digital inverted 
microscope. 
Stage of 
Follicle 
Stage of 
Fish 
Follicle 
Diameter 
Description 
(1) 
Cortical 
Alveolus 
(R) 
Regressed 
175-550 µm Appearance of cortical alveoli (“yolk 
vesicles”) 
(2)  
Vitellogenesis 
(V) 
Vitellogenic 
550-1350 
µm 
Ooplasm is opaque, membrane-bound 
yolk spheres occur & germinal vesicle 
visible under microscope 
(3) 
Early 
Maturation 
(EM) Early 
Mature 
1350-1700 
µm 
Ooplasm becomes more translucent as 
oocyte matures & several oil droplets 
appear (dispersed) 
(4) 
Late 
Maturation 
(FM) Fully 
Mature 
1700-1900 
µm 
Ooplasm becomes more transparent, 
Germinal vesicle breakdown, lipid 
droplets continue to coalesce 
(5) 
Ovulated 
(OV) 
Ovulated 
1900 µm + Transparent follicles with no apparent 
membrane, covered by coat material 
“jelly” & oil droplets migrate to one pole 
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Figure 2.1. Images of staged follicles across the ovarian development cycle in 
mummichog: (A) cortical alveolus, (B) vitellogenesis, (C) early-mid mature, (D) late 
mature, (E) ovulated. Scale bar is 2000 µm for images A-C and E; scale bar is 1000 µm 
for image D. CAF = cortical alveolus follicle; GV = germinal vesicle; LD = lipid 
droplets. Images obtained from the EVOS XL digital inverted microscope imaging 
system. 
iii) Measurement of steroid hormone levels by EIA 
Steroids were extracted from plasma samples using ethyl-ether (according to 
Gillio-Meina et al., 2013). The extracted samples were dried overnight at room 
temperature and then reconstituted in 500 µL of EIA buffer (Cayman Chemical, Ann 
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Arbor, MI, USA) and stored at -80°C. Media samples from the in vitro incubations were 
assayed without extraction. EIAs for E2, T, and MIS were conducted as per the 
manufacturer’s (Cayman Chemical) instructions. The appropriate dilution for each steroid 
stage and basal or stimulated treatment, was determined by analyzing serial dilutions of 
pooled samples; dilutions used on plasma or media samples were either 2x or 4x. To 
determine if there was interference in the EIA caused by the L-15 media samples, 
standard curves were generated with both L-15 medium and EIA buffer; no differences 
were found. Therefore, media samples were assayed directly in the EIA. Interassays were 
created for each hormone measured; following EIA, the coefficient of variation was 
calculated to be 7% for E2, 13% for T, and 11% for MIS [standard deviation of 
samples/mean of samples x 100], which indicates that the method is reproducible and 
reliable. The samples were read at a wavelength of 420 nm using a Molecular Device 
SpectramaxPlus 384 microplate reader (Molecular Devices, Sunnyvale, CA, USA). Mean 
fold increase (shown to compare hCG-stimulated production to basal production, per 
treatment and stage) was calculated as follows: 
(ℎ𝐶𝐺 𝑣𝑎𝑙𝑢𝑒 𝑏𝑎𝑠𝑎𝑙 𝑣𝑎𝑙𝑢𝑒⁄ ) of sample 1 +  (ℎ𝐶𝐺 𝑣𝑎𝑙𝑢𝑒 𝑏𝑎𝑠𝑎𝑙 𝑣𝑎𝑙𝑢𝑒⁄ ) sample of 2 … + (ℎ𝐶𝐺 𝑣𝑎𝑙𝑢𝑒 𝑏𝑎𝑠𝑎𝑙 𝑣𝑎𝑙𝑢𝑒⁄ ) of sample  N 
𝑁
 
iv) RNA extraction, cDNA synthesis and qPCR 
Total RNA was extracted from frozen ovary (whole ovary or isolated follicles), 
liver and brain tissue, using TRIzol reagent (Invitrogen, Burlington, ON, Canada). The 
protocol was carried out as per the manufacturer’s instructions with minor modifications. 
Ovary and liver samples (20-50 mg), whole brains, or separated follicles (15-40, 
depending on experiment) were added to centrifuge tubes with 800 µL of TRIzol reagent, 
and homogenized via mechanical disruption using a hand-held homogenizer (Knotes 
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Pellet Pestle Cordless Motor, Fisher Scientific), or a 21G (0.8 mm x 25 mm) needle on a 
3 mL syringe. Chloroform (160 µL) was added for the extraction of RNA into the top, 
clear supernatant. The samples were centrifuged at 12,000 x g for 15 minutes at 4oC, after 
which the top RNA layer was decanted into 400 µL of iso-propanol of a correspondingly 
labelled tube, and then centrifuged again at the same parameters. The supernatant was 
discarded, and 800 µL of 75% ethanol was added to the tubes containing the RNA pellet, 
then the tubes were centrifuged at 7,500 x g for 5 minutes at 4oC. The ethanol layer was 
poured off and the pelleted RNA was dissolved in 10-60 µL (depending on size of pellet) 
of RNase-free water. The samples were then vortexed briefly, heated at 55-58oC for 5-10 
minutes to fully dissolve the RNA pellet, and stored at -80oC. 
RNA yield was verified using a Nanodrop 8000 (Thermo Fisher Scientific, 
Burlington, ON) with 2 µL of samples at two dilutions of 10 and 50x to allow for an 
accurate calculation of the undiluted RNA. RNA samples were then diluted to 1000 
ng/µL with molecular grade water, for use in the cDNA reactions. RNA sample quality 
was checked at a 260/280 nm wavelength, and samples were read between 1.6 and 2.0. A 
subset of 10x diluted RNA samples were randomly selected from each experiment to 
verify RNA integrity using RNA StdSens Chips on the Experion Automated 
Electrophoresis Station (Bio-Rad Laboratories, Mississauga, ON, Canada) as per the 
manufacturer’s instructions.  
RNA samples were treated for potential genomic DNA contamination with the 
AMP-D1 kit (Sigma Aldrich) according to the instructions prior to cDNA synthesis. 2 µL 
of 1000 ng/µL RNA was added to a 0.2 mL PCR tube containing 6 µL of RNase-free 
water, 1 µL of 10 x Reaction Buffer and 1 µL of DNAse enzyme. The samples were 
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heated at 70oC for 10 minutes [using a C1000 PCR thermocycler (Bio-Rad Laboratories)] 
and then chilled on ice. Reverse transcription of total RNA was performed with 4 µL of 
iScript Reverse Transcription Supermix (Bio-Rad Laboratories) and followed the 
manufacturer’s instructions, with parameters of 5 min at 25oC for priming, 30 min at 
42oC for RT (reverse transcription), 5 min at 85oC for inactivation, and cooling to 4oC. 
The resulting cDNA was stored at -20oC until real-time quantitative PCR (qPCR) 
analysis.   
qPCR was performed in duplicate for each sample using SsoFast EvaGreen 
Supermix and the CFX96 Real-Time System (Bio-Rad Laboratories) in a reaction 
volume of 10 µL containing 2.5 µL of cDNA, 5 µL EvaGreen, 1.25 µL of each forward 
and reverse primers. The qPCR parameters were 30 seconds at 95oC, followed by 40 
cycles of 95oC for 1 second and 55oC for 5 seconds, which was the annealing temperature 
determined to be best suited for all of the primers through a series of temperature gradient 
tests. To demonstrate primer specificity and the amplification of a single amplicon, 
dissociation curves were conducted on all reactions. Genomic DNA and RT-water 
controls were conducted on approximately 10% of the samples and were found to be free 
of contamination. 
Oligonucleotide primers for most genes of interest were designed using IDT 
PrimerQuest Tool, and obtained from either Sigma-Aldrich or IDT [Integrated DNA 
Technologies (Coralville, IA, USA)]. Table 2.2 presents the primer sequences and their 
NCBI GenBank accession numbers. The relative standard curve qPCR method was used 
and six-point standard curves were generated for each gene with primer efficiency values 
shown in Supplementary Table S2.1. 
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Genes of interest were normalized to a reference gene, which was shown to not 
change expression levels in female mummichog undergoing ovarian development (data 
shown in Figure S2.1, S2.2, and S2.3). The reference genes used were estrogen receptor 
β1 (ESR2a) in the ovary, 18sRNA in the liver, and EF1α in the brain. 
Table 2.2. Forward (FWD) and reverse (REV) primer sequences used for qPCR analysis 
with accession numbers and commercial source.  
Gene  Sequence 5’-3’ Accession # Company 
Β-Actin FWD 
REV 
GCA CGG TAT TGT GAC CAA 
GGG TGT TGA AGG TCT CAA 
AF397164 Sigma 
EF1α FWD 
REV 
TCA CCA TCA GCT TTT ATA AAG 
GAC GCT CCA TTG CCT ACT GTC 
AY735180 Sigma 
18s-RNA FWD 
REV 
GTC GTA GTT CCG ACC ATA AAC 
CAC CCA CAG AAT CGA GAA AG 
M91180 IDT 
ESR1 FWD 
REV 
ACT CTA CCA CTG GCT ACT ACT C 
GCT GGT GAC TGG ATC TGT AAA 
AY571785 IDT 
ESR2a FWD 
REV 
GAG GAG CAT CCA AGG ACA TAA C 
TTG GTC ATG CCG ACT TCA TAG 
AY570922 IDT 
ESR2b FWD 
REV 
CTC AGC CGA ACC ACA GTA ATC 
CTC CAG CCA GCA ACA CTT TA 
AY570923 IDT 
LHr FWD 
REV 
TGG AAA CCA TCG AGG CAT TAG 
GAC ATC AGG GAA GAG CGT TAT C 
AB295491 IDT 
FSHr FWD 
REV 
CCA TCT CCT TCT TTG CCA TCT 
CCA TCC AGA CTC AGC GTA TTC 
AB295490 IDT 
StAR FWD 
REV 
CCT TCA AAA GAT CGG ACA GG 
TTT CTG AGG CAT TTG TG 
Doyle et al., 
2013 
IDT 
CYP11a1 FWD 
REV 
TTC AAG GCA GAG GGT CAA TAT C 
AGG TCC GTG GTC CAT TTA TTC 
AB471800 IDT 
CYP17a1 FWD 
REV 
CTG CTT CAA CTC CTC CTA TTC 
CCT TGT GCT CGT TGT ACT T 
XM_012852
073 
(Predicted 
Sequence) 
IDT 
CYP19a1 FWD 
REV 
GTC CAC TCT TGT CTT ATT TG 
GTC TCC TCT CCA TTG ATC 
AY428665 Sigma 
CYP19b FWD 
REV 
CTG TGA GGA CTC AGA AA 
TCA GTG CGA GGT TAT AC 
AY428666 IDT 
Vtg1  FWD 
REV 
GTT GGC ATA CAC TGA GAA 
AGA CGT AAC TTA ATG TTG TG 
AAA93123 Sigma 
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v) Histological assessment  
At the time of dissection and based on gross morphology, ovaries were classified 
according to Table 2.1 if approximately ≥75% of the follicles present within the ovary 
appeared to be in the desired stage (1 – 5). Histological assessments of approximately 
25% (N= 3-4 per stage) of the ovaries were conducted to ensure the ovaries contained a 
majority of the desired stage of follicle (Figure 2.2). Follicle diameter was measured with 
the EVOS XL digital inverted microscope imagining system (Figure 2.1). Histological 
assessments of subsamples of the ovaries verified these classifications (Figure 2.2). 
Pieces of whole ovary were placed into cassettes [7x12 mm Tissue Path MACROSETTE 
Processing/Embedding Cassettes (Fisher Scientific)], immersed in 10% buffered formalin 
(Fisher Chemical, Ottawa, ON, Canada) and processed by the University of Guelph 
Animal Health Laboratory. Samples were paraffin embedded, cross-sectioned at 4 µm at 
3 different levels, stained with standard haemotoxylin and eosin, and mounted on slides 
using Tissue Tek permanent mounting medium (Sakura Finetek, Torrance, CA, USA). 
Slides were examined under a Zeiss Axio Upright Observer Microscope (Carl Zeiss, 
Toronto, ON) under 5-10x magnification, using ZEN Pro Software (Carl Zeiss, Toronto, 
ON) to determine the stage of ovarian development and to allow for measurements of the 
diameters of the follicles as shown in Table 2.1.  
2.3.3 Molecular characterization of the biosynthetic pathway of ovarian follicles 
 In order to characterize the expression of genes across follicular stages of 
development and provide a comparison of the expression levels determined in whole 
ovarian tissue, individual follicles were separated and classified by stage. The females 
used for this work were held at conditions known to be favourable for the continuous 
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production of mature eggs (spawning conditions: 22oC with 16h L: 18h D, as per 
demonstrated in Peterson et al., 2010). The fish were from the same stock used in the 
work described in Section 2.3.2, but were sampled on February 10th and 17th 2017, to 
collect sufficient numbers of follicles at each stage from multiple fish. 
i) Sampling 
Sampling was followed as outlined in section 2.3.2.i and ii with few exceptions. 
The whole ovary was dissected and placed directly into petri dishes containing 75% L-15 
medium, and underwent the sorting process (similar to section 2.3.2.ii). When collecting 
ovulated follicles (stage 5), the abdomen of the fish was slightly squeezed to release the 
ovulated follicles from the abdominal cavity, through the ovipositor. After sorting, the 
isolated follicles were removed from the medium and placed in sterilized 1.5 mL Flat 
Top Microtubes (Diamed, Mississauga, ON) in groups of ~30-40 follicles that were snap-
frozen and stored at -80oC. The total time for this process was under 10 minutes, as each 
fish was processed individually. Gene expression was measured from grouped ovarian 
follicle samples obtained from 7-8 fish for each stage. 
ii) RNA extraction and qPCR 
The RNA extraction and qPCR protocol was followed as outlined in section 
2.3.2.iv with minor modifications. Total RNA was extracted from frozen ovarian follicles 
(30-40 per sample), using TRIzol reagent. Following the extraction procedure total RNA 
was pelleted, rinsed with 75% ethanol, reconstituted in 10-40 µL RNase-free water and 
incubated at 56-59oC for 5-10 minutes to fully dissolve the RNA pellet. Gene expression 
values were normalized to adjusted values of ESR2a, based on the approach described by 
Ings and Van Der Kraak, 2006 (Table S2.1), due to the inability to find a reference gene 
50 
 
which was steadily expressed across all stages. Stage 5 (ovulated) follicles produced non-
detectable amounts of gene expression, so they were excluded from gene expression 
analysis data.  
iii) Histology assessment 
The histology protocol was followed as outlined in section 2.3.4.v, with the 
exception of storing the isolated follicles in 15mL disposable, polypropylene centrifuge 
tubes (Fisher Scientific) containing ~5mL of 10% buffered formalin. These centrifuge 
tubes were sent to the University of Guelph Animal Health Laboratory to be processed 
for histological analysis. 
2.3.4 Effect of EE2 on basal and hCG-stimulated ovarian follicles: steroid 
production and gene expression 
 To assess the effect of EE2 on gene expression and hormone production at the 
gonadal level in mummichog, staged ovarian follicles were exposed to 50-250 nM of EE2 
over a 24 h incubation period, as simplified in Figure S2.5. The fish used in this 
experiment were from the same stock used in the work described in Section 2.3.2 and 
2.3.3., but were sampled from October 21st 2016 to December 21st 2016, over 11 days in 
order to collect sufficient numbers of follicles at each stage for each treatment, from 
multiple fish. Stock tanks were held at spawning conditions (22oC with 16h L: 18h D) in 
order to obtain ovaries with follicles at various maturation stages. 
i) Sampling 
Sampling was followed as outlined in section 2.3.3.i with minor modifications. 
After the sorting process, the separated follicles were removed from the medium and 
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placed in 1-2 mL of fresh medium in in vitro plate wells. Wells each contained 25 
follicles of a specific stage; the mass of tissue for each well was recorded prior to 
incubation. Regressed ovaries (stage 1) were cut into pieces of 7-8 mg, while in medium, 
with a total of 3 pieces per well (total ~24 mg).  
ii) In vitro methodology 
The in vitro protocol was followed as outlined in 2.3.2ii with a few exceptions, as 
simplified in Figure S2.6B. The follicles were obtained from multiple fish for every stage 
(3-4 individual fish per pool). Each pool was distributed into 11 wells. Each well 
contained 24 mg of tissue (three pieces of 7-8 mg) for regressed (cortical alveoli) ovaries 
or 25 follicles for vitellogenic to ovulated ovaries. There were 11 treatments per stage, 
with a total of 7-8 reps per stage (n = 7-8). The first treatment was time zero; after 
follicles were sorted, samples from each pool were removed from the medium and 
directly snap-frozen, then stored at -80oC. There were five treatments: no solvent control 
(only L-15 medium), solvent (ethanol) control, 50 nM EE2, 100 nM EE2, and 250 nM 
EE2; these treatments were either basal or hCG-stimulated, resulting in a total of 10 
treatments plus one time zero sample per pool/stage. Concentrated stocks of EE2 (Sigma-
Aldrich) were prepared in ethanol at concentrations of 10, 20, and 50 µM, and stored in 
glass vials at -20oC. EE2 and ethanol were added to wells at 5 µL per 1 mL of total 
solution (as per McMaster et al., 2005), resulting in final concentrations of 50, 100 and 
250 nM per well (concentrations are equivalent to 14.82 µg/mL, 29.64 µg/mL, and 74.1 
µg/mL respectively). After incubation, the media were removed, stored at -20oC, and 
used later for steroid hormone measurement of T and MIS through EIA analysis, on a 
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subset of samples (all stage 2, 3 and 4 samples). The tissue was also removed, stored at -
80oC and later used for gene expression analysis. 
iii) RNA extraction and qPCR 
The RNA extraction and qPCR protocol were followed as outlined in section 
2.3.3.ii with the exception that total RNA was extracted from frozen ovarian follicles (25 
per sample), using TRIzol reagent. Gene expression values were normalized to β-actin.  
2.3.5 Statistics 
 Statistical analysis was performed using SPSS 23 (IBM Canada Ltd, Markham, 
ON, Canada). One-way analysis of variance (ANOVA) was performed to assess plasma 
and in vitro steroid hormone levels (E2, T & MIS), or gene expression (ERs, P450 
enzymes, StAR, LHr, FSHr), across the different stages of maturation. Two-way 
ANOVA was performed to assess basal T and MIS production across different stages of 
follicle maturation with different treatments of EE2 (from in vitro exposure). 
Assumptions of normality and homogeneity of variance were tested using Shaprio-Wilk’s 
W test and Levene’s test, respectively. If the data were not normally distributed, or did 
not test positive for homogeneity of variance, the data were log transformed or square-
root transformed (rarely) through SPSS, and the parameters were tested again. If the 
normality and variance tests still failed after data transformation, then the non-parametric 
Games-Howell test was used; Tukey’s test was used for all parametric post hoc analyses. 
In all cases, a p-value of 0.05 was chosen to indicate significance.  
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2.4 Results 
2.4.1 Characterization of the estrogen biosynthetic pathway during ovarian 
development 
i)  Morphometric Data 
Morphometric data, such as body weight, gonad weight and liver weight, were 
recorded from sampled fish and analyzed to determine the mean GSI and LSI for each 
stage of fish. Mean GSI in fish increased with increasing stage of ovarian development 
[minimum at R, 1.72 ± 0.17 %; maximum at OV, 12.36 ± 3.2 %; p = 0.00 (Table 2.3)], as 
did body weight [minimum at R, 10.1 ± 0.55 g; maximum at OV, 17.4 ± 1.0 g; p = 0.00 
(Table 2.3)], and gonad weight [minimum at R, 0.17 ± 0.01 g; maximum at OV, 2.09 ± 
0.45 g; p = 0.00 (Table 2.3)]. Mean LSI in fish remained relatively the same across 
stages, except for an increase in regressed fish [minimum at FM, 3.87 ± 0.32 %; 
maximum at R, 6.53 ± 0.24 %; p = 0.00 (Table 2.3)], and there were no significant 
changes in liver weight across stages [minimum at V, 0.55 ± 0.05 g; maximum at OV, 
0.80 ± 0.11 g; p = 0.20 (Table 2.3)]. 
ii) Plasma hormones in females across the reproductive cycle 
Plasma E2 production was highest compared to T or MIS levels across all stages 
of fish examined (Figure 2.3). R (regressed) refers to fish containing primarily cortical 
alveoli follicles; V (vitellogenic) refers to fish containing primarily vitellogenic follicles; 
EM (early mature) refers to fish containing primarily early mature follicles; FM (fully 
mature) refers to fish containing primarily late mature follicles; OV (ovulated) refers to 
fish containing primarily ovulated follicles. Plasma T levels increased from regressed to 
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fully mature fish and were highest in fully mature fish; fully mature fish were 
significantly higher than regressed or vitellogenic fish [minimum at V, 88.5 ± 21.3 
pg/mL; maximum at FM, 250.0 ± 32.0 pg/mL; p = 0.00 (Figure 2.3 A)]. Mean plasma E2 
significantly increased from regressed to fully mature fish, and dropped in ovulating fish 
[minimum at R, 26.5 ± 3.09 pg/mL; maximum at FM, 2550 ± 339 pg/mL; p = 0.00 
(Figure 2.3 B)]. Mean plasma MIS had no significant changes from regressed to early 
mature fish, but significantly increased form early mature to ovulating fish [minimum at 
V, 0.3 ± 0.1 pg/mL; maximum at OV, 5.0 ± 1.2 pg/mL; p = 0.00 (Figure 2.3 C)].  
iii) In vitro steroid production across follicular stages of ovarian development  
Basal E2 production was highest compared to T or MIS levels across all stages of 
follicles examined (Figure 2.4). Mean basal and hCG-stimulated levels of E2, T and MIS 
(Figure 2.4) dropped between stages 1-2. The decline in basal in vitro hormone 
production seen in stage 2 follicles is most likely due to the difference in tissue weight 
per well (a methodological issue), and the results are focussed on stage 2 to stage 5 
follicles. Basal T significantly increased during stage 4, while having no significant 
differences across stages 2, 3 or 5 [minimum at stage 3, 10.2 ± 1.5 pg/mL; maximum at 
stage 4, 26.5 ± 5.0 pg/mL; p = 0.00 (Figure 2.4 A)]. Basal E2 increased from stage 2 to 
stage 4 [minimum at stage 5, 84.7 ± 25.7 pg/mL; maximum at stage 4, 2096 ± 261 
pg/mL; p = 0.00 (Figure 2.4 C)]. Basal MIS levels significantly increased from stage 2 to 
stage 4, and remained at high levels during stage 5 [minimum at stage 2, 0.96 ± 0.2 
pg/mL; maximum at stage 5, 18.45 ± 7.8 pg/mL; p = 0.00 (Figure 2.4 E)]. hCG-
stimulated T, E2 and MIS production was highest at stage 3, had no significant 
differences between stages 3-4, and had low production during stage 2 and 5 (p = 0.00 for 
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each hormone; Figure 2.4 B, D, F). hCG-stimulated hormone production was highest for 
E2, then MIS, and lowest for T. 
Fold increase of hCG-stimulated to basal production of steroids by separated and 
staged (stages 1 to 5; refer to Table 2.1) follicles were examined to compare hormone 
levels across different stages of maturation, without being influenced by follicle size or 
weight. Early mature (stage 3) follicles showed the greatest capacity to respond to hCG 
treatment and the MIS response seemed most pronounced at this stage given that hCG 
had little stimulatory effect on MIS at all other stages (Figure 2.5). The fold increase 
(hCG-treated to basal hormone levels) of T, E2 and MIS at stage 3 were 25.8 ± 6.9 [p = 
0.00 (Figure 2.5 A)], 5.0 ± 0.8 [p = 0.00 (Figure 2.5 B)], and 243.2 ± 66.7 [p = 0.00 
(Figure 2.5 C)], respectively.  
iv)  Gene expression in females across the reproductive cycle 
Gene expression was determined in whole ovary pieces from fish that were 
sampled over the reproductive cycle having group-synchronous ovaries, characterized as 
containing >75% of a desired stage (based under gross examination under a microscope). 
Follicles were later verified through histological assessment (Figure 2.2) and stage of fish 
was supported with morphometric data (Table 2.3). Ovarian expression data were 
normalized to estrogen receptor ERβ1 (ESR2a) and displayed as the fold change relative 
to the regressed stage. The constant expression of ESR2a across all ovarian 
developmental stages is shown in Supplemental Figure S2.1.  
Ovarian expression of ESR1 significantly increased in vitellogenic fish and had 
no significant changes in expression throughout the rest of maturation [minimum at R, 
1.0 ± 0.2; maximum at FM, 4.8 ± 0.5; p = 0.00 (Figure 2.6 A)]. Ovarian ESR2b 
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expression peaked in regressed fish, dropped in vitellogenic fish and had no significant 
differences in expression throughout the rest of maturation [minimum at OV, 0.2 ± 0.1; 
maximum at R, 1.0 ± 0.3; p = 0.00 (Figure 2.6 B)]. Expression of FSHr in ovary peaked 
in early mature fish and had no significant differences between early maturation to 
ovulation [minimum at R, 1.0 ± 0.2; maximum at EM, 8.9 ± 2.5; p = 0.00 (Figure 2.6 C)]. 
Ovarian expression of LHr increased from regressed to fully mature fish, and decreased 
in ovulating fish [minimum at R, 1.0 ± 0.3; maximum at FM, 56.6 ± 15.7; p = 0.00 
(Figure 2.6 D)].  
All steroidogenic enzymes increased in expression throughout the ovarian 
development cycle. StAR expression was highest in ovulating fish [minimum at R, 1.0 ± 
0.1; maximum at OV, 184.1 ± 92.9; p = 0.00 (Figure 2.7 A)]. CYP11 expression was 
highest in fully mature fish [minimum at R, 1.0 ± 0.1; maximum at FM, 21.4 ± 6.8; p = 
0.00 (Figure 2.7 B)]. CYP17 expression was highest in fully mature and ovulating fish 
[minimum at V, 0.7 ± 0.1; maximum at OV, 4.3 ± 1.3; p = 0.002 (Figure 2.7 C)]. 
CYP19a1 peaked in fully mature fish [minimum at V, 0.7 ± 0.2; maximum at FM, 6.2 ± 
3.0; p = 0.00 (Figure 2.7 D)].  
Liver gene expression was analyzed from whole liver tissue dissected from fish 
that were sampled over the reproductive cycle having ovaries characterized as containing 
>75% of a desired stage. Liver expression data were normalized to 18sRNA and 
displayed as the fold change relative to the regressed stage. The constant expression of 
18sRNA across all ovarian developmental stages is shown in Supplemental Figure S2.2. 
Expression of ESR1 in the liver increased throughout the cycle, and was highest 
in ovulating fish [minimum at R, 1.0 ± 0.1; maximum at OV, 2.5 ± 0.4; p = 0.00 (Figure 
57 
 
2.8 A)]. VTG1 expression is associated with ESR1 expression trends [minimum at R, 1.0 
± 0.2; maximum at OV, 26.8 ± 1.8; p = 0.00 (Figure 2.8 D)]. Expression of ESR2a 
decreased throughout the cycle, with no significant changes between early maturation to 
ovulation [minimum at FM, 0.2 ± 0.0; maximum at R, 1 ± 0.1; p = 0.00 (Figure 2.8 B)]. 
Expression of ESR2b peaked at in vitellogenic fish, with low expression and no 
significant changes in all other stages [minimum at R, 1.0 ± 0.13; maximum at V, 11.1 ± 
1.8; p = 0.00 (Figure 2.8 B)].  
Brain gene expression was analyzed from whole brain tissue dissected from fish 
that were sampled over the reproductive cycle having ovaries characterized as containing 
>75% of a desired stage. Brian expression data were normalized to EF1α and displayed 
as the fold change relative to the regressed stage. The constant expression of EF1α across 
all ovarian developmental stages is shown in Supplemental Figure S2.3. There were no 
significant changes in expression of CYP19b across the ovarian development cycle 
[minimum at OV, 0.8 ± 0.3; maximum at V, 1.2 ± 0.1; p = 0.61 (Supplemental Figure 
S2.4)].  
2.4.2 Molecular Characterization across Follicular Stages in the Maturation Cycle   
Using additional fish, gene expression in follicles isolated by 100% stage were 
assessed. Gene expression in stages 1-5 (refer to Table 2.1) were measured and verified 
through histological analysis. Stage 5 (ovulating) was excluded as qPCR results showed 
non-detectable expression (with the exception of ESR2b). Follicular expression data were 
normalized to adjusted values of ESR2a and displayed as the fold change relative to stage 
1. The formula used for adjusting ESR2a values is found in Supplementary Table S2.1. 
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Follicular expression of ESR1 had no significant differences amongst stages 1-3; 
however, stage 4 (late mature) was significantly lower than stage 2 (vitellogenic) 
[minimum at stage 4, 0.7 ± 0.1; maximum at stage 2, 1.6 ± 0.1; p = 0.00 (Figure 2.9 A)]. 
Expression of ESR2b decreased across maturation [minimum at stage 5 (ovulated), 0.0 ± 
0.0; maximum at stage 1 (cortical alveoli), 1 ± 0.3; p = 0.00 (Figure 2.9 B)]. FSHr 
expression peaked during stage 2, and had low expression with no significant differences 
across all other stages [minimum at stage 4, 0.7 ± 0.3; maximum at stage 2, 6.4 ± 0.7; p = 
0.00 (Figure 2.9 C)]. LHr expression increased across maturation until stage 3 (early 
mature) [minimum at stage 1, 1 ± 0.3; maximum at stage 4, 19.0 ± 2.1; p = 0.00 (Figure 
2.9 D)].   
Follicular expression of StAR and CYP11 increased throughout the cycle. StAR 
had highest expression during stage 4 (late mature) [minimum at stage 1, 1 ± 0.09; 
maximum at stage 4, 171.5 ± 76.0; p = 0.00 (Figure 2.10 A)], and CYP11 peaked during 
stage 3 (early mature) [minimum at stage 1, 0.9 ± 0.2; maximum at stage 3, 6.1 ± 1.4; p = 
0.00 (Figure 2.10 B)]. Expression of CYP17 peaked during stage 1 (cortical alveoli) and 
had minimal expression across stages 2-4 (vitellogenic – late mature) [minimum at stage 
3, 0.0 ± 0.0; maximum at stage 1, 1 ± 0.2; p = 0.00 (Figure 2.10 C)]. There were no 
significant changes in expression of CYP19a1 between stages 1-3 (cortical alveoli – early 
mature); however, there was a significant decrease in expression at stage 4 (late mature) 
[minimum at stage 4, 0.2 ± 0.1; maximum at stage 2, 1.3 ± 0.2; p = 0.00 (Figure 2.10 D)].  
59 
 
2.4.3 Effect of EE2 on Basal and hCG-stimulated Follicular Steroid Production and 
Gene Expression  
Gene expression in follicles (stages 1-4; cortical alveoli, vitellogenic, early 
mature, and late mature) isolated by stage (e.g., stage 2 contained 100% follicles at stage 
2) were assessed after in vitro incubation with varying EE2 treatments. The medium was 
removed and utilized for hormone analysis and the tissue was utilized for gene expression 
analysis. The basal and hCG-stimulated steroid results of the in vitro incubations from 
ovarian follicles (stages 2-4), treated with 50, 100 and 250 nM EE2 are shown in Table 
2.4. As expected, basal T and MIS levels increased significantly with increased 
maturational stage of the ovarian follicles [for T, p = 0.00 from Two-way ANOVA; for 
MIS p = 0.00 from Two-way ANOVA (Table 2.4)]; however, the steroid levels were 
unaffected by EE2 treatments (50, 100 and 250 nM) at all stages examined. There was no 
significant effect of EE2 on basal T levels (for stages 2-4, p = 0.11, 0.09, and 0.67, 
respectively (Table 2.4)) or hCG-stimulated T levels (for stages 2-4, p = 0.51, 0.36, and 
0.57, respectively (Table 2.4)) for any stage of maturation analyzed. There was no 
significant effect of EE2 on basal MIS levels (for stages 2-4, p = 0.88, 0.26, and 0.97 
(Table 2.4)) or hCG-stimulated MIS levels (for stages 2-4, p = 0.44, 0.69, 0.98, 
respectively (Table 2.4)) for any stage of maturation analyzed. hCG-stimulated 
incubations produced significantly higher levels of hormone for both T and MIS during 
stages 2-4 (p < 0.05; data not shown).  
Follicular expression data were normalized to β-actin, and displayed as the fold 
change relative to the time 0-hour control. There were no significant effects of EE2 
treatment on CYP19a1 expression for any stage of follicular development (Table 2.5). 
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There was a significant increase in CYP19a1 expression with hCG stimulation for stages 
2, 3 and 4 (for stages 1-4, p = 0.00, 0.03, 0.00, 0.00). Time 0 expression was greater than 
basal 24 h expression for all stages, but varied per stage for hCG-stimulated expression. 
Stage 1: time 0 > 24h expression, stage 2: time 0 = hCG-stimulated 24 h expression, 
stage 3 and 4: time 0 < hCG-stimulated 24 h expression. There was no significant effect 
of EE2 treatment on LHr (luteinizing hormone) expression for any stage of follicular 
development as well (Table 2.5). hCG stimulation had no effect on LHr expression for 
either stage (for stages 1-4, p = 0.21, 0.71, 0.09, 0.43). Time 0 expression was equal to 24 
h expression levels for stages 1-4, however the basal control was significantly lower than 
time 0 expression at stage 3.  
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Figure 2.2 Images of ovarian tissue sampled from mummichog over the developmental 
cycle to provide examples of the ovaries staged as A) regressed (primarily stage 1), B) 
vitellogenic (primarily stage 2), C) early mature (primarily stage 3), D) fully mature 
(primarily stage 4), E) ovulated (primarily stage 5). Scale bar is 200 µm. PN = 
perinucleolar; CA = cortical alveolar; GV = germinal vesicle; PV = previtellogenic; V = 
vitellogenic; YP = yolk proteins; EM = early mature; M = mature; PO = post ovulated; 
JC = jelly coat. H&E stained sections were prepared by the University of Guelph 
Histology Laboratory. 
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Table 2.3. Mean (± SEM) body weight, gonad weight, liver weight, gonadosomatic and liversomatic index of female mummichog 
sampled with ovaries containing a majority of cortical alveoli (regressed), vitellogenic, early mature, late mature (fully mature) or 
ovulated follicles. Different letters indicate significant differences for the GSI and LSI. P = 0.00 for body weight, gonad weight, GSI 
and LSI. P = 0.198 for liver weight. 
Sample Date Stage Body Weight 
(g) 
Gonad Weight 
(g) 
Liver Weight 
(g) 
GSI (%) LSI (%) N 
December 
2015 
Regressed 10.12 ± 0.55 A 0.17 ± 0.01 A 0.65 ± 0.04 A 1.72 ± 0.17 A 6.53 ± 0.24 A 20 
April 2016 Vitellogenic 13.39 ± 0.47 AB 0.44 ± 0.07 B 0.55 ± 0.05 A 3.30 ± 0.51 B 4.12 ± 0.39 B 10 
April 2016 Early Mature 15.58 ± 0.85 BC 1.07 ± 0.10 C 0.66 ± 0.07 A 6.78 ± 0.34 C 4.21 ± 0.43 B 14 
April 2016 Fully Mature 14.54 ± 0.77 BC 1.23 ± 0.08 C 0.56 ± 0.05 A 8.58 ± 0.57 CD 3.87 ± 0.32 B 14 
May 2016 Ovulating 17.40 ± 1.02 C 2.09 ± 0.45 D 0.80 ± 0.11 A 12.36 ± 3.2 D 4.54 ± 0.36 B 4 
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Figure 2.3 Mean (±SEM) plasma testosterone (A), 17β-estradiol (B), and maturation 
inducing steroid (C) levels (pg/mL) characterized over the developmental cycle in female 
mummichog with ovaries containing a majority of cortical alveoli (regressed: R), 
vitellogenic (V), early mature (EM), late mature (fully mature: FM) or ovulated (OV) 
follicles. Different letters indicate significant differences. The number of females 
sampled at each point were 15, 12, 16, 14, and 4, respectively, for each hormone. 
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Figure 2.4. Mean (±SEM) follicular in vitro production of basal testosterone (A), hCG-
stimulated testosterone (B), basal 17β-estradiol (E2; C), hCG-stimulated E2 (D), basal 
maturation inducing steroid (MIS; E), and hCG-stimulated MIS (F) levels (pg/mL), 
characterized over the ovarian development cycle in cortical alveoli (stage 1), 
vitellogenic (stage 2), early mature (stage 3), late mature (stage 4) and ovulated (stage 5) 
follicles. Different letters indicate significant differences. N = 10, 14-15, 11-13, 13-15, 
and 8-9 for stages 1-5, respectively. 
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Figure 2.5. Fold increase of hCG-stimulated to basal hormone production of testosterone 
(A), 17β-estradiol (B) and maturation inducing steroid (C) characterized over the ovarian 
development cycle in cortical alveolus (stage 1), vitellogenic (stage 2), early mature 
(stage 3), late mature (stage 4) and ovulated (stage 5) follicles. Different letters indicate 
significant differences. N = 10, 14-15, 11-12, 13-15, and 8-9 for stages 1-5, respectively. 
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Figure 2.6. Expression of ESR1 (A), ESR2b (B), FSHr (C), and LHr (D) in mummichog 
whole ovaries dominated by cortical alveoli (regressed: R), vitellogenic (V), early mature 
(EM), late mature (fully mature: FM) or ovulated (OV) follicles. Data were normalized to 
ESR2a and displayed as the fold change relative to the R stage. Values represent the 
mean ± S.E.M. N= 8-9, 10, 14, 14, and 4, for stages 1-5, respectively, as determined by 
qPCR. Different letters indicate significant differences.  
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Figure 2.7. Expression of StAR (A), CYP11 (B), CYP17 (C), and CYP19a1 (D) in 
mummichog whole ovaries dominated by cortical alveoli (regressed: R), vitellogenic (V), 
early mature (EM), late mature (fully mature: FM) or ovulated (OV) follicles. Data were 
normalized to ESR2a and displayed as the fold change relative to the R stage. Values 
represent the mean ± S.E.M. N= 9, 10, 14, 14, and 4, for stages 1-5, respectively, as 
determined by qPCR. Different letters indicate significant differences.  
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Figure 2.8. Liver expression of ESR1 (A), ESR2a (B), ESR2b (C), and VTG1 (D) in 
mummichog with ovaries dominated by cortical alveoli (regressed: R), vitellogenic (V), 
early mature (EM), late mature (fully mature: FM) or ovulated (OV) follicles. Data were 
normalized to 18sRNA and displayed as the fold change relative to the R stage. Values 
represent the mean ± S.E.M. N= 12, 10, 13-14, 12-14, and 4, for stages 1-5, respectively, 
as determined by qPCR. Different letters indicate significant differences.   
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Figure 2.9. Stage specific expression of ESR1 (A), ESR2b (B), FSHr (C), and LHr (D) in 
mummichog with cortical alveoli tissue (stage 1), vitellogenic (stage 2), early mature 
(stage 3), and late mature (stage 4) follicles. Data were normalized to adjusted values of 
ESR2a and displayed as the fold change relative to stage 1. Values represent the mean ± 
S.E.M.  N= 8-9, 8, 9, and 7-8, for stages 1-4, respectively; N= 7 for stage 5 (ESR2b only) 
as determined by qPCR. Different letters indicate significant differences.  
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Figure 2.10 Stage specific expression of StAR (A), CYP11 (B), CYP17 (C), CYP19a1 
(D) in mummichog with cortical alveoli tissue (stage 1), vitellogenic (stage 2), early 
mature (stage 3), and late mature (stage 4) follicles. Data were normalized to adjusted 
values of ESR2a and displayed as the fold change relative to stage 1. Values represent the 
mean ± S.E.M. N= 8-9, 8, 8-9, and 7-8, for stages 1-4, respectively, as determined by 
qPCR. Different letters indicate significant differences. 
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Table 2.4 Unstimulated (basal) and human chorionic gonadotropin (hCG)-stimulated testosterone (T) and maturation inducing steroid 
(MIS) levels from ovarian follicles at different stages of maturation [stage 2 (vitellogenic), stage 3 (early mature), stage 4 (late 
mature)], exposed to solvent control (ethanol; s ctrl) and increasing concentrations of 17α-ethinyl estradiol (EE2). The hormone levels 
are presented as mean ± S.E.M. values (pg/mL). Mean fold increase is shown to compare hCG-stimulated production to basal 
production, per treatment and stage. There are no significant differences in T or MIS production among treatments (solvent control, 50 
nM EE2, 100 nM EE2, 250 nM EE2) per stage, within groups (basal or hCG-stimulated). There are no significant differences in fold 
increase among treatments, per stage. hCG-stimulated hormone production is significantly higher than basal hormone production, per 
stage, for each hormone. Average basal hormone production significantly increases with stage, for each hormone. N = 7-8 for each 
treatment per stage. P-values from statistical tests performed on T and MIS data are found in Supplementary Table S2.2. 
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Hormone EE2  
Treatment 
Stage 2 Stage 3 Stage 4 
Basal hCG+ Fold Increase Basal hCG+ Fold Increase Basal hCG+ Fold 
Increase 
T S Ctrl 8.3 ± 
1.2 
30.3 ± 
4.9 
4.0 ± 0.6 26.2 
± 4.1 
235.5 
± 52.0 
14.1 ± 4.1 66.2 ± 
16.5 
237.2 ± 
59.9 
5.63 ± 
2.4 
50 nM 9.6 ± 
1.1 
24.3 ± 
3.8 
2.0 ± 0.5 25.5 
± 4.2 
143.8 
± 15.7 
9.7 ± 3.9 74.6 ± 
13.2 
193.3 ± 
68.4 
5.05 ± 
2.2 
100 nM 11.8 
± 0.9 
21.5 ± 
3.1 
1.9 ± 0.3 28.7 
± 4.3 
217.4 
± 35.1 
9.5 ± 2.7 64.4 ± 
11.4 
267.0 ± 
58.9 
4.9 ± 1.5 
250 nM 13.5 
± 1.0 
32.3 ± 
6.7 
2.4 ± 0.6 32.8 
± 4.1 
249.4 
± 37.9 
7.6 ± 1.4 61.2 ± 
12.5 
247.6 ± 
47.9 
5.8 ± 1.5 
MIS S Ctrl 1.8 ± 
0.4 
30.8 ± 
17.2 
48.8 ± 20.0 12.2 
± 2.1 
1456.2 
± 
508.8 
216.5 ± 90.7 35.0 ± 
8.4 
247.4 ± 
45.7 
14.9 ± 
5.8 
50 nM 1.9 ± 
0.5 
43.1 ± 
16.9 
46.3 ± 13.4 13.0 
± 3.3 
1220.3 
± 
199.6 
187.0 ± 64.5 36.4 ± 
9.4 
396.3 ± 
126.6 
14.3 ± 
4.0 
100 nM 1.7 ± 
0.4 
24.3 ± 
8.0 
23.1 ± 12.1 12.7 
± 3.1 
1486.1 
± 
436.2 
188.6 ± 53.4  35.7 ± 
8.9 
301.1 ± 
68.3 
19.0 ± 
6.9 
250 nM 2.1 ± 
0.3 
56.7 ± 
18.4 
32.3 ± 9.38 12.9 
± 2.7 
1518.4 
± 
286.9 
135.1 ± 31.7 34.1 ± 
8.8 
485.5 ± 
176.0 
28.3 ± 
10.9 
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Table 2.5 Unstimulated (basal) and human chorionic gonadotropin (hCG)-stimulated P450 aromatase (CYP19a1) and luteinizing 
hormone receptor (LHr) gene expression of ovarian follicles at different stages [stage 1 (cortical alveolus), stage 2 (vitellogenic), stage 
3 (early mature), stage 4 (late mature)] of maturation exposed to solvent control (ethanol; s ctrl) and increasing concentrations of 17α-
ethinyl estradiol (EE2). Gene expression is presented as fold increase to the 0-hour control, per stage, normalized to β-actin (mean ± 
S.E.M). values (pg/mL). One-way ANOVA was completed to assess gene expression of CYP19a1 or LHr among treatments (basal or 
hCG-stimulated 0-hour control, solvent control, 50 nM EE2, 100 nM EE2, 250 nM EE2) per stage. Different letters, or astericks, 
indicate significant differences among treatments, within stages of an individual gene. There were no significant differences among 
treatments, within stages of LHr expression. N = 7-8 for each treatment per stage. (p>0.05, ANOVA followed by Tukey post-hoc test). 
P-values from statistical tests performed on CYP19a1 and LHr data are found in Supplementary Table S2.3. 
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Gene EE2 
Treatment 
Stage 1 Stage 2 Stage 3 Stage 4 
Basal hCG+ Basal hCG+ Basal hCG+ Basal hCG+ 
CYP19a1 O h 1 ± 0.24 *  1 ± 0.15 B  1 ± 0.21 C  1 ± 0.32 A  
S Ctrl 0.23 ± 
0.04 
0.23 ± 
0.06 
0.06 ± 
0.01 A 
1.22 ± 
0.40 B 
0.07 ± 
0.01 A 
6.11 ± 
1.65 B 
0.19 ± 
0.04 A 
5.67 ± 
2.12 B 
50 nM 0.18 ± 
0.02 
0.20 ± 
0.04 
0.07 ± 
0.02 A 
1.82 ± 
0.40 B 
0.09 ± 
0.02 A 
7.37 ± 
1.82 B 
0.27 ± 
0.10 A 
5.90 ± 
1.71 B 
100 nM 0.21 ± 
0.05 
0.18 ± 
0.02 
0.08 ± 
0.02 A 
1.14 ± 
0.27 B 
0.09 ± 
0.02 A 
6.22 ± 
1.26 B 
0.28 ± 
0.07 A 
7.01 ± 
2.38 B 
250 nM 0.18 ± 
0.01 
0.25 ± 
0.04 
0.10 ± 
0.03 A 
1.94 ± 
0.53 B 
0.09 ± 
0.01 A 
5.10 ± 
0.90 B 
0.30 ± 
0.06 A 
7.06 ± 
1.88 B 
LHr O h 1 ± 0.14  1 ± 0.27  1 ± 0.13   1 ± 0.13  
S Ctrl 1.00 ± 
0.14 
1.19 ± 
0.14 
1.18 ± 
0.30 
0.91 ± 
0.20 
0.65 ± 
0.09  
0.62 ± 
0.09 
0.54 ± 
0.13 
0.71 ± 
0.12 
50 nM 1.62 ± 
0.12 
1.10 ± 
0.21 
1.44 ± 
0.51 
0.92 ± 
0.18 
0.86 ± 
0.12 
0.67 ± 
0.11 
0.65 ± 
0.25 
0.59 ± 
0.05 
100 nM 1.30 ± 
0.17 
1.37 ± 
0.09 
1.18 ± 
0.24  
0.69 ± 
0.17 
0.79 ± 
0.11 
0.62 ± 
0.05 
0.63 ± 
0.11 
0.76 ± 
0.16 
250 nM 1.07 ± 
0.13 
1.47 ± 
0.35 
1.18 ± 
0.35 
0.74 ± 
0.14 
0.76 ± 
0.14 
0.71 ± 
0.08 
0.64 ± 
0.12 
0.79 ± 
0.12 
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2.5 Discussion 
This study further develops the estuarine mummichog as a model species for 
understanding the reproductive physiology of teleosts. The study confirmed that, similar 
to other work in mummichog (Lin et al., 1987), E2 is produced by the ovarian follicles 
from the cortical alveolus stage to late maturation, distinguishing this species from many 
other teleosts, in which E2 levels rise from cortical alveolus to completion of 
vitellogenesis and drop prior to maturation (Clelland and Peng, 2009).  It is the first study 
to demonstrate changes in gonadal steroidogenic enzymes and ERs, hepatic VTG1 and 
ERs, and brain aromatase gene expression across the stages of female mummichog 
maturation. The expression of ERs, VTG1 and CYP19a1 are associated with patterns of 
plasma and in vitro E2 levels throughout ovarian development, while CYP17 expression 
is not associated with the patterns of E2. While other studies have suggested that ovarian 
LHr and aromatase gene expression are estrogen-responsive in fish (Liu et al., 2013; 
Lyssimachou et al., 2006), addition of EE2 to in vitro ovarian follicle incubations had no 
effect.  Overall, these studies support the hypothesis that the tolerance exhibited by 
mummichog to exogenous estrogens could be partly attributable to continuously high 
levels of E2 present in the maturing ovary. 
Plasma T and E2 were measured in female mummichog throughout 
recrudescence, in reproductively regressed to ovulating fish; plasma hormone patterns of 
T and E2 were generally similar to those previously demonstrated in mummichog (Lin et 
al., 1987; Shimizu 2003). Plasma T levels were highest in fully mature fish, with no 
significant differences between regressed and early mature stages. This is similar to 
Shimizu (2002), in which plasma levels of T dramatically increased in pre-spawning 
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periods; T levels dropped dramatically during the late spawning-post spawning period 
(Shimizu 2002). Given T’s role as the precursor to E2 in the maturing ovary (Nagahama 
and Yamashita, 2008; Sabet et al., 2009), it is not surprising in the present study that 
higher levels of plasma T generally associated with higher levels of plasma E2. Plasma E2 
levels increased dramatically from regressed to fully mature stages with significant 
differences between the progressive stages of maturation. These findings are similar to 
Shimizu (2002), in which a substantial increase in plasma E2 was demonstrated during 
pre-spawning periods, and eventually dropped significantly during the late-spawning to 
post-spawning period. T and E2 production trends in this study differ from other fish 
species, as plasma T and E2 levels peak during the pre-spawning period in rainbow trout 
(Oncorhynchus mykiss; Whitehead et al., 1978), goldfish (Carassius auratus; Schreck & 
Hopwood, 1974), and caspian kutum (Rutilus kutum; Sabet et al., 2009). Plasma T rose in 
association with E2 and reaching reproductive maturity in common carp (Cyprinus 
carpio; Taghizadeh et al., 2013), and ribbed gunnel (Dictyosoma burger; Hwang et al., 
2012). Plasma T and E2 levels rose in association with vitellogenesis in catfish 
(Heteropneustes fossilis; Lamba et al., 1983), rainbow trout (Zohar and Billard, 1984), 
and Persian sturgeon (Acipenser persicus; Hosseinzade et al., 2012). Plasma E2 levels 
from previous studies ranged from 1500 pg/mL in spring to 11000 pg/mL in the summer, 
750 pg/mL in autumn, and back to 1500 pg/mL in late autumn/early winter (Shimizu et 
al., 2003). Plasma E2 levels from the current study are dependent on stage of ovarian 
development and appear to be expressed at a lower range when compared to Shimizu et 
al. (2003) work; however, this could be caused due to the differences in sub-species of 
mummichog utilized in the studies, as well as differences in methodology. Although 
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difficult to compare between species and studies, plasma E2 levels in mummichog within 
the current study were lower than plasma E2 levels measured in rainbow trout and Persian 
sturgeon during peak production; however, plasma E2 in mummichog were much higher 
than plasma E2 levels in common carp (Hosseinzade et al., 2012; Taghizadeh et al., 2013; 
Whitehead et al., 1978). Reproductive processes in teleost fish are controlled and 
regulated by a balance and interconnectivity among various hormones; these hormones 
also regulate other processes such as growth and development and osmoregulation 
(Menuet et al., 2005; McCormick, 2011; Ramezani-Fard et al., 2013). The association of 
changes in gonadal steroid plasma levels with gonad condition has been proven to be 
valuable in understanding the endocrine control of reproduction in teleosts, as hormone 
levels detected in plasma can be produced from tissues other than the gonads, such as the 
interrenal glands (Cornish, 1998). T and E2 plasma results from the current study suggest 
plasma T and E2 are dependent on the stage of ovarian development, verifies previous 
mummichog work, and confirms T and E2 are regulated differently in mummichog as 
compared to other teleosts.   
T and E2 production were measured from basal (control) and stimulated (with 
hCG: analogue to LH) ovarian in vitro incubations from reproductively maturing fish 
(regressed to ovulating). The in vitro steroid production in regressed ovaries is most 
likely artificially high because of a higher tissue weight per well for regressed ovarian 
tissue compared to vitellogenic follicles. Fold changes of hCG-stimulated to basal steroid 
production, between regressed and vitellogenic ovaries, did not differ; therefore, the 
decline in hormone production seen in vitellogenic follicular in vitro incubations is most 
likely due to the difference in tissue weight per well, and therefore, the interpretation of 
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results is focussed on vitellogenic to ovulated stages. Focussing on vitellogenic to 
ovulated stages, higher levels of unstimulated in vitro T generally associated with high 
levels of unstimulated in vitro E2. Unstimulated in vitro T levels were highest during late 
maturation, and had no significant differences in expression among the vitellogenic, early 
maturation and ovulated stages, whereas E2 levels significantly increased throughout the 
cycle and peaked during early to late maturation. These results are similar to previous 
mummichog work, in which Lin et al. (1987) determined that T production from basal 
follicles peaked during maturational stages, and that E2 production from basal follicles 
consistently increased throughout the cycle and peaked during maturational stages. This 
differs from other teleosts, as a shift is usually present when E2 levels rise throughout the 
earlier stages of the ovarian development cycle, and drop prior to early maturation to 
allow for significantly increased levels of MIS, which are required to complete 
maturation of the oocyte (Nagahama and Yamashita, 2008). This shift was not 
demonstrated in the current study, nor in previous mummichog work (Lin et al., 1987). In 
zebrafish, unstimulated in vitro T and E2 levels increase during growth stages of the cycle 
and drop prior to early maturation (Clelland and Peng, 2009). In vitro T and E2 
progressively rise through the ovarian development cycle and drop during the late stages 
of vitellogenesis in rainbow trout (Breton et al., 1975), amago salmon (Oncorhynchus 
rhodurus; Kagawa et al., 1983), and goldfish (Kagawa et al., 1984). In vitro E2 
production from ovarian follicles across development in mummichog from the current 
study are similar to previous mummichog studies as Lin et al. (1987) demonstrated a 
range of ~900-1500 pg/mL of E2, varying by stage of ovarian development. However, E2 
levels from the current study is much higher than E2 production in amago salmon ovarian 
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follicles (Kagawa et al., 1983). In the current study, unstimulated in vitro T and E2 trends 
associated with their respective plasma trends; this suggests that the majority of T and E2 
produced is from the gonads, similar to most female vertebrates (Thomas, 2008). This 
study confirms previous mummichog studies and suggests that T and E2 production 
correlate with vitellogenesis, as well as with final maturation in mummichog without an 
E2 drop prior to maturation; as noted in the following, this warrants further investigation 
into the regulation of the steroiodgenic pathway during maturation in mummichog.  
This is the first study to measure plasma MIS levels in recrudescing mummichog. 
MIS levels increased significantly from early maturation to ovulating stages, and were 
dissimilar to T and E2 as MIS did not drop off after maturation. These findings from the 
current study are similar to other species such as rainbow trout, in which serum MIS 
levels were highest in female rainbow trout, rockfish (Sebastes taczanowskii) and amago 
salmon undergoing final oocyte maturation and ovulation (Campbell et al., 1980; 
Nagahama et al., 1991; Young et al. 1983), or in ribbed gunnel during spawning and 
post-spawning (Hwang et al., 2012). In the current study, unstimulated in vitro MIS 
trends followed similar trends as MIS plasma, with the exception that in vitro MIS 
increased significantly between vitellogenic and late maturation ovarian follicles, and 
plasma significantly increased between late maturation and ovulation. This suggests a 
time lag between gonadal production and manifestation in the plasma of MIS, perhaps 
due to the low levels of MIS produced relative to T and E2. These findings are similar to 
Lin et al. (1987) which demonstrated that MIS production from stimulated follicles (basal 
MIS levels were non-detectable) peaked during late vitellogenesis – early maturation 
stages. These findings from the current study are also similar to in vitro MIS production 
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trends in other teleosts, even though no dramatic shift in the steroidogenic pathway from 
E2 to MIS was detected prior to oocyte maturation. Follicular MIS levels peak during 
early maturation in zebrafish (Clelland and Peng, 2009), and in maturing and ovulated 
follicles in amago salmon (Young et al., 1983). MIS was confirmed to be the primary 
inducer of GVBD (germinal vesicle breakdown) in amago salmon, rainbow trout and 
goldfish post-vitellogenic oocytes (Nagahama, 1983). This study suggests the rise in MIS 
is the primary event which triggers final oocyte maturation, as opposed to the proceeding 
decline in E2 levels usually found in other teleosts. The action of MIS on final oocyte 
maturation is not direct as it is mediated by a complex interaction of several factors, such 
as cytoplasmic factor and MPF (maturation promoting factor) (Nagahama and 
Yamashita, 2008; Senthilkumaran et al., 2004); therefore, the cause of increasing plasma 
and in vitro MIS levels in ovulating mummichog can be influenced by multiple other 
factors. This study has only considered the presence of T, E2 and MIS across maturation 
in mummichog. Other steroid hormones and gonadotropins, such as progesterone, FSH 
and LH, are involved in ovarian development and can possibly influence the production 
of plasma and in vitro T, E2 and MIS, directly or indirectly (Hosseinzade et al., 2012), 
which warrants further studies.  
hCG-stimulated in vitro T, E2 and MIS hormone production was significantly 
higher than unstimulated in vitro hormone production. hCG is able to stimulate oocyte 
maturation and ovulation in many teleosts, in the same fashion as LH (Harvey and Hoar, 
1979; Zuberi et al., 2011). Oocyte maturation in teleosts is typically first initiated by an 
LH surge in maturing oocytes, which triggers the production of 17α-hydroxyprogesterone 
from the thecal cells, which is then converted into MIS (Nagahama and Yamashita, 2008; 
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Patino and Sullivan, 2002). The current study demonstrated that the steroidogenic 
response of ovarian follicles to hCG is highly dependent on the stage of maturation; early 
mature, followed by late mature ovarian follicles, were most responsive to hCG, as they 
exhibited the highest increase in hormone production from unstimulated in vitro 
production. This differs from previous studies, as Lin et al. (1987) showed a maximal 
increase in hormones T, E2 and MIS in late vitellogenic follicles with FPE (Fundulus 
pituitary extract; acts similar to LH in terms of maturation induction) stimulation; 
however, the differences in stage response could be due to differences between FPE and 
hCG. In other teleosts, such as catfish, hCG production causes maximal production of T 
in maturing follicles, and a maximal production of E2 in vitellogenic follicles (Kagawa et 
al., 1984). Similarly, in amago salmon, SG-G100 (purified chinook salmon 
gonadotropin) could stimulate E2 in vitellogenic follicles, whereas T could be stimulated 
in maturing follicles (Kagawa et al., 1983). Since hCG displays LH bioactivity as it binds 
to gonadal LH receptors and stimulates ovarian development and maturation (Mananos et 
al., 2009), the present study suggests that maturing follicles (primarily early mature) in 
mummichog are most LH-responsive and presumably will have the highest expression of 
LH receptors, which can be confirmed with the gene expression data of LH receptors 
from this study. E2 has been shown to reduce the action of hCG in gonadal incubations of 
goldfish ovaries (Post, 1994). It is worthwhile to further examine how mummichog 
ovaries can consistently respond to hCG with continuously high levels of E2 produced 
until late maturation. 
The current study is the first to examine gene expression changes in the 
steroidogenic enzymes and receptors within the ovary (whole tissue and isolated 
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follicles), liver and brain, across the ovarian development cycle in mummichog (from 
reproductively regressed to ovulating). This study showed differences in expression 
trends between whole ovary tissue and isolated follicles (separated per group), which 
demonstrated different regulation patterns of these steroidogenic enzymes and receptors 
between isolated follicles and whole ovary tissue. The expression results from isolated 
follicles provide an accurate representation of steroidogenic receptor and enzyme activity 
from specific follicular stages (cortical alveolus, vitellogenic, early mature, late mature, 
and ovulated); because mummichog are group-synchronous spawners, ovarian sections 
from regressed, vitellogenic, early mature, fully mature and ovulating fish containing 
follicular mixes (>75% stage-dominant, ~25% other) provide a less precise representation 
of follicular-specific activity. Therefore, the focus of the discussion will be on the 
isolated follicles (by 100% stage). Stage 5 (ovulated follicles) were excluded from 
analysis because expression levels were non-detectable.  
Gene expression of enzymes in the steroidogenic pathway (StAR, CYP11, 
CYP17, and CYP19a1) were measured and characterized across stages in the maturing 
ovary. The steroidogenic pathway is involved in the enzymatic synthesis of sex steroids 
from cholesterol. StAR (aids in the transport of cholesterol across the mitochondrial 
membrane) continues to increase in expression throughout the ovarian development cycle 
and peaks during the later stages. These trends in StAR expression parallel the increasing 
pattern of E2 throughout the stages of maturation. StAR expression in the current study is 
similar to StAR expression in rainbow trout (Sreenivasulu and Senthilkumaran, 2009), 
but differs from zebrafish StAR expression as there are no significant changes in 
expression across all stages in zebrafish (Ings and Kraak, 2006). StAR seems to be 
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associated with ovarian development and E2 production. It is possible that increases in 
StAR expression can also be triggered by LH-mediated signaling pathways. As the 
transport of cholesterol is a rate-determining step for steroidogenesis and StAR is the 
putative key rate-limiting mediator in acute regulation of steroidogenesis (Nagahama and 
Yamashita, 2008; Young et al., 2005), it emphasizes the importance of StAR throughout 
oocyte maturation and its possible role in maintaining high levels of steroidogenic 
precursors, such as cholesterol, pregnenolone, and progesterone. 
CYP11 (converts cholesterol to pregnenolone) expression increases throughout 
the ovarian development cycle, peaks in expression during early maturation, and drops in 
expression during late maturation. These trends in CYP11 expression parallel the 
increasing pattern of E2 throughout the stages of ovarian development discussed 
previously. CYP11 expression is also similar to other teleosts (Kumar et al., 2000) as 
CYP11 in catfish increased from ovarian recrudescence to vitellogenesis (elevations in 
CYP11 expression corresponded to E2 production patterns); however, the current study 
differs from zebrafish expression as CYP11 expression decreased throughout the cycle in 
zebrafish (Ings and Van Der Kraak, 2006). CYP11 is a critical enzyme involved in the 
synthesis of major sex hormones, as it catalyzes the enzymatic reaction following the 
rate-limiting step in steroidogenesis (Kumar et al., 2000). In the current study, CYP11 
follows E2 production patterns as it is associated with oocyte maturation, suggesting 
CYP11 expression may mediate production of final steroidogenic hormones.  
CYP17 (P450 C17: converts pregnenolone to 17α-hydroxypegnenolone and then 
to dehydroepiandrosterone, or converts progesterone to 17α-hydroxyprogesterone and 
then androstenedione) peaks in cortical alveolus staged follicles and remains equally and 
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lowly expressed from vitellogenesis to late maturation. CYP17 trends in mummichog are 
similar to those in zebrafish, where CYP17 expression decreases throughout the ovarian 
development cycle (Ings and Van Der Kraak, 2006); however, CYP17 expression trends 
in the current study differ from catfish expression trends as CYP17 expression in catfish 
spiked within spawning ovaries and dropped during regressed and pre-spawning stages 
(Sreenivasulu and Senthilkumaran, 2009). In the current study, CYP17 in mummichog 
does not appear to parallel E2 levels. CYP17 was described as a critical enzyme involved 
in the initiation of maturational events in fish (Senthilkumaran et al., 2004). Thus, the 
lack of increase in the expression of CYP17 throughout recrudescence in mummichog, 
may be explained by the lack of an E2 to MIS switch at maturation, as the expression 
patterns of CYP17 were previously suggested to have a role in the switch (Clelland and 
Peng, 2009). 
CYP19a1 (P450 aromatase: converts T to E2) had no significant differences in 
expression between the cortical alveolus stage and early maturation stage, and 
demonstrated a decline in expression during late maturation. CYP19a1 expression in the 
current study differs from other teleosts. CYP19a1 is suspected to be an estrogen-
responsive gene; CYP19a1 expression correlates with the onset of ovarian recrudescence 
and vitellogenesis in catfish, closely mirroring E2 production trends (Kumar et al., 2000). 
CYP19a1 expression in zebrafish decreases as the ovarian development cycle progresses 
(Ings and Van Der Kraak, 2006), and dramatically declines in expression after 
vitellogenesis in catfish (Kumar et al., 2000) and rainbow trout (Gohin et al., 2010). In 
catfish, CYP19a1 had the most dramatic increase in expression during recrudescence and 
vitellogenesis, when compared to the other P450 enzymes (Kumar et al., 2000), 
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suggesting CYP19a1 is potentially the most crucial enzyme involved in regulating 
hormones (such as E2) for ovarian recrudescence and vitellogensis. This holds true in the 
current study on mummichog as the expression pattern parallels the increasing pattern of 
E2 throughout the stages of ovarian development until early maturation; however, the 
drop off in CYP19a1 expression at late maturation does not follow E2 patterns and 
warrants further studies to determine what may be causing the drop-off in CYP19a1.   
P450 aromatase is also expressed in the brain (CYP19b), which showed no 
significant differences in expression across ovarian development. Because P450 
aromatase is a key enzyme associated with E2 regulation and ovarian development, it was 
important to assess the expression in brain, in addition to the ovary. P450 aromatase was 
similarly expressed between ovary and brain, with the exception that brain expression of 
CYP19b was continuous throughout ovarian development, including ovulation. This 
indicates regulation of local brain E2 production is independent of gonadal 
steroidogenesis, as CYP19b is related to estrogen-dependent neurogenesis, which is 
continuous through adulthood in fish (Forlano et al., 2001; Pellegrini et al., 2007).  
This is the first study to measure gene expression of estrogen receptors (ESR1, 
ESR2a, and ESR2b) across stages in maturing ovary of mummichog. E2 signaling 
pathways involve binding to the different subunits of estrogen receptors in target organs 
to stimulate biological activity (Hall et al., 2001; Nagler et al., 2012). The pattern of ER 
expression should correlate with E2 biological function and regulation; however, ERs 
could be down-regulated in some tissue as E2 increases to regulate E2 effects. For 
example, ERs in goldfish ovary, liver and brain demonstrated differential patterns of all 
ER-subtype expression during ovarian development, potentially altering ER-mediated 
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processes across tissues (Marlatt et al., 2008). RT-PCR was applied to determine the 
tissue distribution of ERs in mummichog and found that all ER subtypes were primarily 
found in the gonad or liver of males and females, but sex differences in mRNA levels 
were gene- and tissue-specific (Greytak and Callard, 2007). 
Follicular expression of ESR1 paralleled E2 trends, as ESR1 expression had no 
significant differences between the cortical alveoli and early mature stages, and then 
significantly decreased in expression during late maturation. ESR1 is the only subtype 
that has been linked to biological function, i.e. vitellogenin synthesis in liver and E2 
regulation in ovary (Chakraborty et al., 2011). ESR1 trends are generally similar to 
Greytak and Callard (2007)’s study which demonstrated an increase in ovary ESR1 
expression in reproductively active female mummichog, compared to reproductively 
inactive female mummichog. Mummichog ESR1 expression in the current study is also 
similar to other teleosts, as Nagler et al. (2012) demonstrated low and relatively 
unchanging ESR1 expression in the ovary of rainbow trout. ESR2a expression in the 
current study remained stable across the stages in ovary, whereas ESR2b expression 
peaked in the cortical alveolus stage and decreased throughout the cycle. ESR2a 
expression patterns generally follow Greytak and Callard (2007)’s study as they 
demonstrated no changes in expression between reproductively active or inactive gonadal 
ESR2a expression; however, ESR2a expression patterns from the current study do not 
follow patterns in other teleosts such as rainbow trout. Mummichog ESR2b expression 
patterns from the current study do not follow Greytak and Callard (2007)’s study as they 
demonstrated no changes in expression between reproductively active or inactive gonadal 
ESR2b expression; however, mummichog ESR2b expression patterns from the current 
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study are similar to other teleosts (Nagler et al., 2012). Nagler et al. (2012) also showed 
that ESR2a was expressed much higher than ESR2b, with both ERβ subtypes having 
expression which peaked during earlier stages in follicular development and gradually 
decreased until spawning began. In the current study, the various estrogen receptor 
subtypes other than ESR1, are expressed differently throughout the cycle, in differing 
tissues, and are not always associated with the pattern of E2. The function of ERβ 
subtypes has not been determined, but ERβ subtypes can be further examined in various 
tissues to determine whether their expression across the ovarian development cycle 
correlates to endocrine mediators, such as gonadotropins, steroids, or intracellular 
regulators.  
ESR1 and VTG1 expression in the liver were associated with E2 regulation, in 
which ESR1 expression was highest during ovulation, and VTG1 expression peaked 
during ovulation. Vitellogenin (a female-specific lipoprotein) is synthesized in the liver 
under the stimulation of ovarian E2 and is secreted into the blood and transported to the 
ovary where it is taken up into the oocytes to stimulate egg yolk protein production 
during development of the oocyte (Hoar et al., 1983). It is expected that ESR1 expression 
in the liver will be associated with VTG1 expression, as ESR1 is linked to E2 function. 
Hepatic ESR1 expression in mummichog in the current study differed from other teleosts, 
as ESR1 expression in rainbow trout remained fairly static until the end of the spawning 
period, and then significantly increased in post-spawning fish (Nagler et al., 2012). 
VTG1 expression, on the other hand, corresponds to other teleosts as VTG1 expression in 
zebrafish liver is tightly coupled to an increase in E2 activity within maturing females 
(Levi et al., 2009). In the current study, hepatic ESR2a peaked during the cortical 
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alveolus stage and decreased throughout the cycle, whereas ESR2b peaked during 
vitellogenesis and had low expression across all other stages. Neither ESR2a nor ESR2b 
patterns follow expression patterns in other teleosts. In rainbow trout, ESR2a had a 
significant peak in expression in regressed stages, and ESR2b showed a sharp decrease in 
regressed stages (Nagler et al., 2012). These results from the current study suggest that 
ESR1 expression is closely related to E2 levels and vitellogenin expression within 
mummichog; the relationships for estrogen receptors ERβ1 and ERβ2 with ovarian 
development are still unclear. 
Gonadotropin receptors (FSHr and LHr) expression was measured and 
characterized across stages in the maturing ovary. Gonadotropins are regulated through 
the expression of their corresponding receptors; expression of the gonadotropin receptor 
genes vary with reproductive state, partly due to feedback of FSH, LH and steroids 
including E2, T and MIS (Moles et al., 2007). In the current study, follicular expression 
of FSHr peaked during vitellogenesis and had low expression in all other stages. These 
follicular FSHr results corresponded to previous mummichog work (Ohkubo et al., 
2013), which demonstrated a peak in follicular FSHr expression during vitellogenesis as 
well. The follicular FSHr results from the current study also corresponded with other 
teleosts, as FSHr expression is expected to peak near vitellogenesis and drop prior to 
maturation (Clelland and Peng, 2009). In zebrafish, FSHr increased from the primary 
growth stage to vitellogenesis, where it peaked (Kwok et al., 2005). FSH is primarily 
involved in regulating gonadal steroidogenesis in the early ovarian developmental stages, 
especially during vitellogenesis (Ohkubo et al., 2013; Swanson et al., 1991). FSH’s 
dominant role in vitellogenesis is to stimulate E2 production and release from ovarian 
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follicles (Nagahama and Yamashita, 2008); it also influences the increase in P450 
aromatase expression in vitellogenic follicles, as noted in brown trout (Montserrat et al., 
2004). These expression trends from the current study suggest that FSHr correlates to 
FSH is presumed actions on steroidogenesis during follicular growth and vitellogenesis; 
however, FSHr is not associated with the increasing E2 levels in maturing mummichog 
follicles. It may be that once stimulated, E2 levels are maintained by other factors 
including intracellular receptors, cAMP (cyclic adenosine monophosphate) / pKA 
(protein kinase A) pathway factors and calcium channels involved in intracellular signal 
transduction pathways (Matagne et al., 2005; Menuet et al., 2005). 
Follicular LHr expression patterns exhibited low expression during the cortical 
alveolus stage, a peak in expression during vitellogenesis to early mature stages, and no 
significant differences in expression between vitellogenesis to late maturation stages. The 
follicular LHr results from the current study did not correspond to previous mummichog 
work, as Ohkubo et al. (2013) demonstrated a peak in follicular LHr expression during 
early maturation and low expression during vitellogenesis, and late maturation. A reason 
for the discrepancy could be due to methodological differences as cortical alveolus staged 
follicles were included in a separate analysis in Ohkubo et al. (2013)’s study. 
Alternatively, the follicular LHr expression trends from the current study did correspond 
to other teleosts. In zebrafish, LHr expression was low during the early stages of the 
ovarian developmental cycle, but was significantly higher during vitellogenesis, and 
peaked prior to oocyte maturation (Kwok et al., 2005). LH primarily regulates the final 
stages of ovarian development and spawning (Breton et al., 1998; Tyler et al., 1997), 
partially due to its ability to stimulate MIS production from ovarian follicles (Clelland 
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and Peng, 2009; Nagahama and Yamashita, 2008). The surge in LH prior to maturation is 
what is believed to cause the steroidogenic shift in E2 to MIS commonly found in teleosts 
(Nagahama and Yamashita, 2008), as LH is said to inhibit the production of E2 prior to 
maturation (Planas et al., 2000); however, mummichog continue to produce increasing 
amounts of E2 with a high expression of LHr in maturing follicles. In the current study, 
LHr expression is associated with hCG stimulation activity of in vitro hormone 
production, with the exception that LHr is highest in vitellogenic and early maturation 
follicles, whereas hCG stimulation caused the largest increase in hormone production 
within early maturation and late maturation follicles. This could indicate that the increase 
in gonadotropin receptors is required before the increase in gonadotropin occurs. It would 
be beneficial to analyze FSH and LH levels across maturation in mummichog in further 
studies to determine whether gonadotropin levels correlate with the patterns of their 
receptors. The present study suggests that similar to other species, LHr expression 
correlates to MIS levels and LH stimulation of maturation and this relationship is 
independent of an E2 decline. 
Basal and hCG-treated ovarian follicles, grouped by stage of ovarian 
development, were exposed to 50-250 nM of EE2 for 24 hours, in vitro. The experiment 
sought to examine the effect of EE2 on the in vitro production of T and MIS, and on the 
gene expression of CYP19a1 and LHr. The goal was to provide insight on whether 
tolerance exhibited by mummichog in vivo to exogenous estrogens may be partly 
attributable to a lack of response to EE2 at the level of the ovary. The rationale for the 
experimental design (concentration range and exposure time) was from previous in vitro 
exposures of fish ovarian and liver cells to EE2. Hepatic cells in rainbow trout 
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demonstrated a 20-30% increase in expression change of VTG1 to 1-10 nM of EE2 in 
vitro after 24 hours (Hultman et al., 2015); zebrafish hepatocytes demonstrated a 1- to 
10-fold increase in ER and VTG1 expression with 100 nM of EE2 in vitro for 24 hours 
(Eide et al., 2014); and zebrafish ovarian cells demonstrated approximately a 10-fold 
increase in LHr expression with 5 µM EE2 in vitro for 24 hours (Liu et al., 2013). 
Adult female mummichog responses are generally resistant to in vivo EE2 
exposure compared to other fish species. For example, egg production is not decreased at 
nominal concentrations of 100 ng/L, or 84.1 ± 6.0% of nominal, for 28 days (Bosker et 
al., 2016), female plasma E2 levels were not affected after a 14-day exposure to 250 ng/L 
of EE2 (Doyle et al., 2013), and male and female plasma T levels were not affected after 
a 14-day exposure to 500 ng/L (nominal) of EE2, or 247.9 ± 12.3 (average) ng/L (Hogan 
et al., 2010). There was no effect of EE2 in the current study on either T or MIS 
production (E2 was not measured due to high cross-reactivity to EE2 in the EIA analysis), 
or gene expression (CYP19a1 and LHr) at any follicular stage. The results validate the 
hypothesis that mummichog are more tolerant to EE2 than other teleosts. Liu et al. (2013) 
conducted a 24 h EE2 in vitro exposure at 5 µM on zebra fish ovarian cells, causing an 
approximate 10-fold increase in LHr expression; the ED50 (median effective dose) for 
EE2 was 17.9 pM at 1.5 hours, which was similar to the ED50 of E2 (exposed at 5 nM).  
hCG stimulation increased both hormone production and CYP19a1 expression in 
incubated follicles. That hCG stimulation did not increase LHr expression at any stage of 
maturation (cortical alveolus – late mature) was unexpected, as MIS levels did increase 
with hCG stimulation. In Liu et al.’s (2013) study, the use of hCG resulted in an increase 
in LHr expression in zebrafish; there was a 5-fold increase in LHr expression with only 
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hCG stimulation, and an 8-fold increase in LHr expression with a combination of hCG 
and 5µM EE2. Expression patterns of other steroidogenic enzymes can be explored to 
provide insight on this discrepancy, such as 20β-HSD, which should increase in 
expression after the induction of LH or hCG during oocyte maturation (Senthilkumaran et 
al., 2002).The hormone and gene expression results after EE2 in vitro exposure adds 
weight to the idea that mummichog ovarian follicles are resistant to exogenous estrogen, 
and the previous work in the current study suggests high levels of E2 in maturing follicles 
may cause this lack of sensitivity. It would be beneficial to further explore the extent of 
EE2, in vitro, on mummichog ovarian follicles, with a broader concentration range and a 
number of incubation time periods. The explanation for the lack of increase in LHr 
expression with hCG also needs to be further explored as it could be contributing to the 
lack of response to EE2 in mummichog.  
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2.6 Conclusions  
The current study provides confirmation of a continuously increasing production 
of E2 in maturing follicles, supplemented by new molecular analysis of the gene 
expression of key steroidogenic enzymes and hormone/gonadotropin receptors across the 
ovarian steroidogenic pathway in mummichog. These differences exhibited in 
mummichog ovarian development, along with no effect of exposure to EE2 on maturing 
follicles, support the hypothesis that high estrogen levels during oocyte maturation may 
be responsible for reduced sensitivity in mummichog to environmental estrogens. I.e. the 
exposure of mummichog in vivo to EE2 does not manifest in molecular or biochemical 
changes in the ovary, which in other fish is associated with cessation in egg production or 
altered physiological steroid levels, as the ovary is adapted to continuous levels of E2 
during maturation.  
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Appendix A: Supplementary Material 
Adjusting Normalizing Gene Calculation 
When no gene was found to be steadily expressed across stages, such as in experiment 1C 
(EE2 in vitro exposure), the gene that was most steadily expressed was adjusted through a 
calculation (Ings and Van Der Kraak, 2006) to have constant expression. The calculation 
is as follows: 
Adjusted Value = 
𝐼𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙 𝐼𝑛𝑝𝑢𝑡 𝑉𝑎𝑙𝑢𝑒
𝑀𝑒𝑎𝑛 𝐺𝑟𝑜𝑢𝑝 𝐼𝑛𝑝𝑢𝑡 𝑉𝑎𝑙𝑢𝑒 ÷ 𝑀𝑒𝑎𝑛 𝑜𝑓𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝐺𝑟𝑜𝑢𝑝 𝐼𝑛𝑝𝑢𝑡 𝑉𝑎𝑙𝑢𝑒 
 
Reference group refers to the treatment group chosen to which to adjust all other 
treatment groups. For instance, stage 1 was chosen as the reference group.  
Stage 1 Mean = 0.0318 
Stage 2 Mean = 0.0038 
Stage 2 individual value example (fish #10) = 0.0042 
Final adjusted value example (fish #10) = 0.0355 
Standard Curve Equation Values 
Table S2.1 Slope and y-intercept from standard curves of all primers used in this study. 
Enzyme/Receptor Gene Tissue Slope Y-Intercept 
P450 Aromatase Brain CYP19b Brain -3.3379 25.396 
Elongation Factor 1α EF1α Brain -3.7111 18.86 
Estrogen Receptor α ESR1 Liver -3.5421 24.344 
Estrogen Receptor β1 ESR2a Liver -3.7906 27.974 
Estrogen Receptor β2 ESR2b Liver -3.2274 26.309 
Vitellogenin VTG1 Liver -3.7368 14.545 
18s RNA 18sRNA Liver -3.7313 9.4068 
Estrogen Receptor α  ESR1 Ovary -3.1784 28.321 
Estrogen Receptor β1  ESR2a Ovary -3.4627 27.244 
Estrogen Receptor β2 ESR2b Ovary -3.3403 26.485 
Follicle Stimulating Hormone 
Receptor 
FSHr Ovary -3.3691 26.8 
Luteinizing Hormone Receptor LHr Ovary -3.5261 26.57 
Steroidogenic Acute Regulatory 
Protein 
StAR Ovary -3.1238 26.84 
P450 Side Chain Cleavage CYP11a1 Ovary -3.2424 24.798 
P450 C17 CYP17a1 Ovary -3.0117 27.577 
P450 Aromatase CYP19a1 Ovary -3.4627 24.672 
β-Actin Actin Ovary -3.2588 16.477 
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Normalizing Genes 
 
Figure S2.1. Expression (raw input values) of ESR2a in mummichog whole ovaries 
dominated by cortical alveoli (regressed: R), vitellogenic (V), early mature (EM), late 
mature (fully mature: FM) or ovulated (O) follicles. Values represent the mean ± S.E.M.  
(N = 9, 10, 14, 14, 4 for stages 1-5, respectively) as determined by qPCR. There were no 
significant changes across expression. (p = 0.298, ANOVA followed by Tukey post-hoc 
test). 
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Figure S2.2. Expression (raw input values) of 18sRNA in liver tissue from mummichog 
with ovaries dominated by cortical alveoli (regressed: R), vitellogenic (V), early mature 
(EM), late mature (fully mature: FM) or ovulated (OV) follicles. Values represent the 
mean ± S.E.M. N = 12, 10, 14, 14, 4 for stages 1-5, respectively, as determined by qPCR. 
There were no significant changes across expression. (p = 0.547, ANOVA followed by 
Tukey post-hoc test). 
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Figure S2.3. Expression (raw input values) of EF1α in brains from mummichog with 
ovaries dominated by cortical alveoli (regressed: R), vitellogenic (V), early mature (EM), 
late mature (fully mature: FM) or ovulated (OV) follicles. Values represent the mean ± 
S.E.M. N = 12, 11, 15, 14, 4 for stages 1-5, respectively, as determined by qPCR. There 
were no significant changes across expression. (p = 0.726, ANOVA followed by Tukey 
post-hoc test).  
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Additional Methods FlowCharts and Diagrams  
 
Figure S2.4. Simplified flowchart of experimental protocols undertaken for hormone 
analysis (plasma and in vitro), histology, and gene expression of whole tissue (ovary, 
liver, and brain), explained in sections 2.3.2 of the methods. 
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Figure S2.5. Simplified flowchart of experimental protocols undertaken for hormone 
analysis and gene expression of separated ovarian follicles after a 24-hour EE2 in vitro 
exposure, explained in sections 2.3.4 of the methods. 
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Figure S2.6. Example in vitro plate setups for hormone analysis of basal and hCG 
(human chorionic gonadotropin)-treated follicles across ovarian development (A), 
explained in methods section 2.3.2 ii, and for hormone and gene analysis of the EE2 in 
vitro exposure of ovarian follicles across ovarian development (B), explained in methods 
section 2.3.4 ii.   
B 
A 
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Brain Gene Expression Analysis 
 
Figure S2.7. Expression of CYP19b in brains from mummichog with ovaries dominated 
by cortical alveoli (regressed: R), vitellogenic (V), early mature (EM), late mature (fully 
mature: FM) or ovulated (OV) follicles. Values represent the Mean ± S.E.M. N = 12, 11, 
15, 14, 4 for stages 1-5, respectively, as determined by qPCR. Data were normalized to 
EF1α and displayed as the fold change relative to the R stage. There were no significant 
changes across expression. (p = 0.256, ANOVA followed by Tukey post-hoc test). 
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Table S2.2. P-Values from statistical tests performed on T (testosterone) and MIS 
(maturation inducing steroid) hormone data from 24-hour in vitro ovarian follicles at 
different stages of development [stage 2 (vitellogenic), stage 3 (early mature), stage 4 
(late mature)] incubations with EE2 treatments (control, solvent control, 50 nM EE2, 100 
nM EE2, 250 nM EE2) between groups (basal or hCG-stimulated). 
Hormone/ 
Stage 
2-way ANOVA 
(Stage & Basal 
Treatments) 
1-way 
ANOVA 
(Stages from 
Basal only) 
1-way ANOVA 
(Basal EE2 
Treatments) 
1-way 
ANOpVA 
(hCG+ EE2 
Treatments) 
1-way ANOVA 
(Fold Increase) 
T 0.822 0.00    
2   0.114 0.513 0.088 
3   0.093 0.363 0.281 
4   0.669 0.574 0.939 
MIS 0.779 0.00    
2   0.884 0.439 0.208 
3   0.258 0.688 0.842 
4   0.976 0.981 0.834 
 
Table S2.3. P-Values from statistical tests performed on CYP19a1 (P450 aromatase) and 
LHr (luteinizing hormone receptor) gene expression data from 24-hour in vitro ovarian 
follicles at different stages of development [stage 1 (cortical alveolus), stage 2 
(vitellogenic), stage 3 (early mature), stage 4 (late mature)] incubations with EE2 
treatments (basal or hCG-stimulated: control, solvent control, 50 nM EE2, 100 nM EE2, 
250 nM EE2). 
Gene Stage 1-way ANOVA among 
Treatments within Stage 
CYP19a1 1 0.00 
 2 0.03 
 3 0.00 
 4 0.00 
LHr 1 0.21 
 2 0.71 
 3 0.09 
 4 0.43 
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3.1 Summary  
This thesis further develops the estuarine mummichog as a model species for 
understanding the reproductive physiology of teleosts. It has been confirmed that, similar 
to other work in mummichog (Lin et al., 1987), 17β-estradiol (E2) is produced by the 
ovarian follicles from the regressed (cortical alveolus) stages to late maturational stages, 
distinguishing this species from many other teleosts, in which E2 levels rise from cortical 
alveolus to completion of vitellogenesis and drop prior to maturation (Clelland and Peng, 
2009). In most teleost fish, there is a marked shift from estrogens (such as E2) to 
progestogens (such as maturation inducing steroid; MIS) as follicles progress to early 
maturation. However, in mummichog there is no shift detected, as levels of E2 are 
consistently higher in all stages of follicular development. Mummichog have also been 
noted to be more tolerant to exogenous estrogen exposure, such as 17α-ethinyl estradiol 
(EE2), compared to commonly studied teleosts; most freshwater species will respond to 
environmentally-relevant concentrations (Armstrong et al., 2016), whereas mummichog 
respond to much higher concentrations (if at all) (Bosker et al., 2016). The differences in 
ovarian physiology and EDC (endocrine disrupting compound) responses amongst 
species led to the hypothesis that provides the foundation for this thesis, which is that 
continuous high levels of E2 produced in the maturing mummichog ovary may be a 
reason for the species’ increased tolerance to EE2 exposure. 
Plasma (from blood), ovary, liver and brain tissue, and ovarian follicles, were 
collected from maturing mummichog and grouped into five stages of maturation; 
follicular steroid production and/or gene expression in hormone signaling and 
steroidogenic pathways were assessed by stage. Plasma and follicular production of E2 
117 
 
increased as the ovarian development cycle progressed, and dropped after maturation; 
MIS, however, was equally expressed during development and early maturation stages, 
and increased in late maturation and ovulation stages. T (testosterone) levels 
corresponded with E2 trends, whereas MIS peaked during late maturational stages. This 
study also demonstrated that the steroidogenic response of ovarian follicles to hCG 
(human chorionic gonadotropin) is highly dependent on the stage of maturation; early 
mature, followed by late mature ovarian follicles, were most responsive to hCG. Because 
hCG mimics LH (luteinizing hormone) bioactivity, as it binds to gonadal LH receptors 
(LHr) and stimulates ovarian development and maturation (Mananos et al., 2009), the 
present study suggests that maturing follicles (primarily early mature) in mummichog are 
the most LH-responsive. This study suggests that T and E2 production correlates with 
vitellogenesis and final maturation in mummichog, whereas MIS correlates only with 
final maturation, with no E2 drop prior to maturation. 
The current study is the first to examine changes in gene expression of 
steroidogenic enzymes and receptors within the ovary (whole tissue and isolated 
follicles), liver and brain, across the ovarian development cycle (from reproductively 
regressed to ovulating) in mummichog. StAR (steroidogenic acute regulatory protein; 
aids in the transport of cholesterol across the mitochondrial membrane), CYP11 (P450 
side-chain-cleavage; converts cholesterol to pregnenolone), and LHr (luteinizing 
hormone receptor; surge in LH prior to maturation is believed to be the main mediator 
causing the steroidogenic shift in E2 to MIS) (Nagahama and Yamashita, 2008) follow 
similar expression patterns as found in other teleosts. StAR and CYP11 follow the 
general pattern of increasing E2 throughout the stages of maturation, whereas LHr shows 
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an increase in expression, primarily with maturation. LH is said to inhibit the production 
of E2 prior to maturation (Planas et al., 2000); however, mummichog continue to produce 
increasing amounts of E2 with a high expression of LHr in maturing follicles. 
Differences between mummichog and other teleosts in maturational gene 
expression include the expression of P450c17 (catalyzes the hydroxylation of 
pregnenolone to yield 17α-hydroxypregnenolone and then dehydroepiandrostone, or the 
hydroxylation of progesterone to yield 17α-hydroxyprogesterone and then 
androstenedione), which drops earlier in the maturation cycle; follicle stimulating 
hormone receptor (FSHr; key gonadotropin responsible for ovarian development), which 
has low expression in the cortical alveolus stage; P450 aromatase (converts T to E2), or 
CYP19a1, which is evenly expressed through all stages prior to dropping at late 
maturation; and estrogen receptor α (ESR1; the only estrogen receptor subtype that has 
been linked to vitellogenin synthesis in liver and E2 regulation (Chakraborty et al., 
2011)), which has no significant differences in expression over the ovarian development 
stages, prior to dropping at late maturation. CYP19a1 and ESR1 follow the general 
increasing pattern of E2 throughout the stages of maturation, whereas CYP17 and FSHr 
do not. The lack of increase in the expression of CYP17 throughout recrudescence in 
mummichog may be explained by the lack of an E2 to MIS switch at maturation, as the 
expression patterns of CYP17 were previously suggested to have a role in the switch 
(Clelland and Peng, 2009). CYP19a1 is suspected to be an estrogen-responsive gene; the 
drop off in CYP19a1 expression at late maturation does not follow E2 patterns and 
warrants further studies to determine what may be causing the decrease in CYP19a1. 
CYP19b (P450 aromatase in brain) on the other hand, showed no significant differences 
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in expression across ovarian development, suggesting regulation of local brain E2 
production is independent of gonadal steroidogenesis. The results from this study suggest 
that ESR1 expression is closely related to E2 levels and vitellogenin expression within 
mummichog; however, the relationships for estrogen receptors ER2a and ER2b with 
ovarian development are still unclear. 
To determine EE2 effects on maturing follicles, grouped follicles were exposed to 
50-250 nM of EE2 for 24 hours, in vitro, with and without hCG stimulation. There was no 
effect on either T or MIS production (E2 was not measured due to high cross-reactivity to 
EE2 in the EIA analysis), or gene expression (CYP19a1 and LHr) at any follicular stage. 
The results validate the hypothesis that mummichog are more tolerant to EE2 than other 
teleosts, as previous studies demonstrated an increase in LHr expression in zebrafish 
ovarian cells after EE2 in vitro exposure (Liu et al., 2013). hCG stimulation increased 
both hormone production and CYP19a1 expression in incubated follicles. It was 
unexpected, however, that hCG stimulation did not increase LHr expression at either 
stage of maturation (cortical alveolus – late mature), as MIS levels did increase with hCG 
stimulation and Liu et al.’s (2013) study demonstrated hCG caused an increase in LHr 
expression. The hormone and gene expression results after EE2 in vitro exposure adds 
weight to the idea that mummichog ovarian follicles are resistant to exogenous estrogen. 
Overall, the current study provided confirmation of a continuously increasing 
production of E2 in maturing follicles, supplemented by new molecular analysis of key 
steroidogenic enzymes and hormone/gonadotropin receptors across the ovarian 
steroidogenic pathway in mummichog. These results, along with no effect of exposure to 
EE2 on maturing follicles, support the hypothesis that high estrogen levels during oocyte 
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maturation may be responsible for reduced sensitivity in mummichog to environmental 
estrogens. However, the mechanism behind the correlation of high estrogen levels during 
oocyte maturation and reduced sensitivity to exogenous estrogens need to be explored 
further.  
3.2 Future Directions 
It has been demonstrated that mummichog are fairly resistant to exogenous 
estrogens such as EE2, when compared to commonly-studied teleost species. Growth and 
reproductive processes in freshwater teleosts, such as fathead minnow (Pimephales 
promelas), zebrafish (Danio reiro), and Chinese rare minnow (Gobiocypris rarus), are 
negatively impacted by exogenous estrogens at environmentally-relevant EE2 
concentrations (ex. 0.1-10 ng/L) (Armstrong et al., 2016; Kidd et al., 2007; Lin and Janz, 
2006; Parrott and Blunt, 2005; Zha et al., 2008). However, mummichog respond to much 
higher concentrations at 100 ng/L or higher (if at all) (Bosker et al., 2016; Gillio Meina et 
al., 2013; Hogan et al., 2010). Currently, the reason for this species-specific sensitivity 
with EE2 is unknown. This thesis aimed to determine if continuously high levels of E2 
present in maturing mummichog ovarian follicles were partially responsible for the 
decreased sensitivity to EE2; results from this thesis have supported this hypothesis. In 
order to further investigate this suggestion, similar experiments from this thesis can be 
conducted on teleosts that are generally more tolerant to EE2 exposure, such as 
sheepshead minnow (Cyprinodon variegates; Zillioux et al., 2001), in order to determine 
if similar patterns of E2 regulation exist during ovarian development.  
The experimental work on EE2 in vitro exposure of mummichog ovarian follicles 
paves the way for more in vitro analysis on the mechanisms of EE2 action. In vitro 
121 
 
exposures of staged ovarian follicles to EE2 have not been completed on any fish species. 
The concentrations used in the current study were chosen after a thorough literature 
research on previous EE2 in vitro exposures conducted on hepatic or ovarian tissue/cells. 
The lack of effect of EE2 on P450 aromatase (CYP19a1), LHr gene expression, or on T 
and MIS hormone production suggests that mummichog ovarian follicles are resistant to 
EE2 exposure at 50-250 nM. It would be beneficial to assess the effect of EE2 at a broader 
concentration range (e.g., 10 pM – 10 uM), as this range is commonly found in EDC in 
vitro exposures (Beitel et al., 2015; Eide et al., 2014; Hultman et al., 2015; Liu et al., 
2013), or to run a concentration-response curve prior to choosing a new concentration 
range. It would also be beneficial to assess the effect of EE2 in vitro in mummichog 
follicles across a time course from 0 – 24 hours, at much shorter and intermediary 
intervals, to determine if there are any molecular effects occurring at a shorter time 
period than 24 hours. This is because EDCs can act on a molecular level within minutes 
(membrane receptors) or hours (nuclear receptors) (Thomas, 2008) and as well that 
effects can be transient (Shanle and Xu, 2011; Vandenberg et al., 2012). In the current 
study, expression of CYP19a1 decreased after the 24-hour incubation, and although LHr 
expression did not decrease after the 24-hour incubation, it is important to determine 
what is happening to CYP19a1 expression before the 24-hour time period, as changes in 
expression can occur rapidly and are transient. Noting these changes in expression prior 
to the 24-hour incubation time point can be vital in determining the rate of perturbation 
on CYP19a1 expression across stages of follicular development. Perhaps there is an 
important piece missing with changes in LHr expression as well, which might provide 
insight on why LHr expression does not decrease after 24 hours of incubation, or increase 
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with hCG stimulation. A positive control could also be added to this study to confirm the 
effect of EE2 on the measured endpoints. Because the mechanism of EE2 on mummichog 
ovarian follicles is not yet known, zebrafish follicles could be used as a positive control 
as it was demonstrated that EE2 has a negative effect on LHr expression in zebrafish 
ovarian cells (Liu et al., 2013). 
As previous EE2 in vitro exposures have been completed on hepatic cells (Beitel 
et al., 2015; Eide et al., 2014), it would also be interesting to conduct an EE2 in vitro 
exposure on liver tissue sampled at various stages of ovarian development, while 
assessing vitellogenin and ERα expression changes. Brain sections could also be 
dissected at various stages of ovarian development, to assess P450 aromatase in the brain, 
as well as gonadotropin receptors and/or estrogen receptors. The data could be analyzed 
alongside gene expression data from the current study measured in liver and brain at 
different stages of ovarian development. This research could then be utilized to compile a 
better understanding of how EE2 is affecting, or not affecting, mummichog through the 
HPG axis.  
In the current study, key receptors and enzymes in the steroidogenic pathway in 
mummichog were characterized by molecular analysis for the first time. This work is 
important to support further development of the mummichog model for EDC bioassay 
work. Estrogen receptors, gonadotropin receptors, vitellogenin, StAR and P450 enzymes 
were characterized across ovarian development in mummichog; however, there are still 
some important genes in the steroidogenic pathway which could be characterized, such as 
20β-HSD (20β-hydroxysteroid dehydrogenase), which catalyzes the conversion of 17α-
hydroxy progesterone to produce MIS (Young et al., 2005). As high levels of MIS 
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coincide with high levels of E2 in mummichog, it would be interesting to see how 20β-
HSD (20β-hydroxysteroid dehydrogenase) is expressed across maturation. The current 
study, along with previous work, emphasizes the importance of developing a thorough 
understanding of comparative endocrinology and physiology among model teleost 
species used in EDC studies. There are other endpoints which can be measured across the 
ovarian development cycle in order to develop a full working model of mummichog; 
these endpoints include furthering the molecular characterization of steroidogenic 
enzymes, signaling pathways, and also more hormones and gonadotropins, etc. (Table 
3.1). Measuring the levels of FSH and LH through EIA (enzymatic immunoassay) 
analysis will be beneficial to see what is happening to these gonadotropins and whether 
their levels correspond with receptor expression. Since LHr showed no increase in 
expression after hCG stimulation in the current study, an analysis of the gonadotropin LH 
with EE2 exposure across ovarian development may provide more insight into this 
question. Filling in the knowledge gaps for mummichog physiology, as well as expanding 
on EE2 exposure studies, will bring us closer to determining the mechanisms of tolerance 
of estrogenic EDCs in mummichog. 
  
124 
 
Table 3.1. Gap analysis chart of endpoints for developing the mummichog model across 
the ovarian development cycle. Endpoints highlighted in green have been completed in 
this study; endpoints highlight in pink have not been completed by any study. 
Characterization of 
Hormones, 
Gonadotropins, etc. 
Molecular 
Characterization of 
Signaling Pathways 
Molecular 
Characterization of 
Steroidogenic Enzymes 
E2 ERα StAR 
T ERβ1 P450scc 
MIS ERβ2 P450c17 
FSH VTG1 P450arom 
LH FSHr 3β-HSD 
VTG LHr 11β-HSD 
Progesterone G-protein coupled receptor 17β-HSD 
Intracellular cAMP levels  20β-HSD 
PKA levels   
 
Further studies need to be completed in order to determine the mechanistic reason 
for why higher E2 levels during oocyte development may cause reduced sensitivity to 
exogenous estrogens, such as EE2. A possible mechanism behind this correlation could be 
associated with estrogen receptors. Ligand binding to ERs is responsible for regulating 
the basic biology of estrogen-sensitive tissues; the use of selective agonists or antagonists 
can modulate this biology (Rich et al., 2002). Therefore, binding activity is an important 
factor to consider. ER competitive binding assays (assess a chemical’s ability to bind to 
an ER) between E2 and EE2 have been completed in other species and could be a valuable 
asset to understanding the mechanistic effects of EDCs in mummichog (Blair et al., 
2000). This could determine whether exogenous estrogens, such as EE2, are capable of 
acting through the same binding mechanisms as endogenous E2. Eventually this would 
demonstrate whether E2 has a higher binding affinity to ERs than EE2 in mummichog, 
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and thus is displacing EE2 from ERs more so than in other fish. Further studies could also 
be completed on the binding affinity of E2 and EE2 to the different ER subtypes within 
various tissues, to get a more thorough understanding of the mechanisms.  
Throughout this thesis, nuclear estrogen receptors were examined thoroughly. 
More work could be completed on membrane receptors and explore the pKA (protein 
kinase)/cAMP (cyclic AMP) pathway further. Ligand binding results in the exchange of 
GDP for GTP on the Galphas protein; its dissociation from the BY subunit complex 
stimulates the enzyme adenyl cyclase (AC) to catalyze the cyclization of ATP to generate 
cAMP and pyro-phosphate (Serezani et al., 2008). Intracellular levels of cAMP are 
tightly regulated by AC and the enzyme phosphodiesterase (PDE) (Serezani et al., 2008). 
An increase in intracellular cAMP levels is an important intracellular signaling 
mechanism involved in the regulation of gene expression (Chen et al., 1999); and 
elevation in intracellular cAMP levels in the ovary is also important in the regulation of 
steroid production, prior to GVBD in synergism with E2 (Lu et al., 2017). This leads to 
the question of whether or not there is an increase in cAMP levels in maturing 
mummichog follicles prior to maturation. A thorough characterization of the enzymes in 
this pathway and intracellular cAMP levels can provide insight on whether the link 
between reduced sensitivity to exogenous estrogens and high levels of E2 in maturing 
oocytes is correlated to a component of this pathway. 
There is also a possibility that the high E2 levels present in maturing mummichog 
oocytes could be a result of adaptation to the environment or due to its asynchronous 
spawning nature. In asynchronous spawners, the pre-vitellogenic, vitellogenic and 
maturation phases almost completely overlap, with vitellogenesis and maturation 
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occurring simultaneously; however, in synchronous spawners, the phases are clear with 
little or no overlap, and in group-synchronous spawners, phases are less clear than 
synchronous spawners and there is little overlap (Wooton and Smith, 2015). These 
different patterns in oocyte dynamics can be caused by either radically different control 
mechanisms for clear distinct phases, or a shift in temporal patterns for non-distinct 
phases (Wooton and Smith, 2015). It would be interesting to determine what selective 
factors cause these dynamic changes in oocyte development and maturation, through 
evolutionary analysis of the species mummichog. 
3.3 Integrative Nature of this Study 
This study expanded the current understanding of reproductive physiology in 
mummichog by linking endpoints across various biological levels. These include the 
whole organism (e.g., hormone levels from blood (plasma)), organ (e.g., gonad size, liver 
size, characterization of ovarian stage through histological analysis,), physiological (e.g., 
hormonal production from ovarian tissue and follicles) and molecular (e.g., gene 
expression of various steroidogenic enzymes and receptors in different tissues) levels. 
The endocrine system is one of the key signalling integrators in organisms; a thorough 
assessment across these biological levels enhances our understanding for mummichog 
and general fish reproductive physiology. This study also analyzed the effects of EE2 on 
mummichog ovarian follicles across maturation, which furthers our interpretation of EE2 
effects under various reproductive circumstances (e.g., at different stages of ovarian 
development).  
With the results from this study, we can develop a better understanding of 
mechanisms of action of EDCs and link these results to the field of toxicology. We can 
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utilize the results gained from this study to support the development of toxicological tools 
that investigate the mechanisms of action of EDCs, including those compounds that, 
similar to EE2, have estrogenic mechanisms of action. The knowledge of the mechanism 
of action of certain substances can also supplement other studies which have addressed 
these issues on a larger ecological scale. Through integration, the work from this study 
can be utilized to determine the effect of EDCs (such as EE2) at various biological levels 
across species, the mechanisms of action or tolerance of EE2 across species, and 
ultimately can lead to improving risk assessment of pollutants (such as exogenous 
estrogens) over a large scale, and protection of Canadian water systems. 
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